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Abstract 
A meta-ethnography approach synthesised themes found in the qualitative literature 
examining the experience of being diagnosed with epilepsy.  Eleven studies were assessed 
and five super-ordinate themes emerged of ‘initial onset’, ‘diagnosis complications’, 
‘information sources’, ‘time to process’, ‘adjustment and role change’ and ‘relationship with 
healthcare staff’. ‘Relationship with healthcare staff’ affects all the super-ordinate themes 
apart from ‘initial onset’.  Moreover, patients value the relationship in its own right and the 
importance of this relationship is highlighted and discussed.  The results would support 
interventions that aim to increase the awareness of epilepsy signs amongst hospital and 
school staff and adds to the literature suggesting relationships form a key part in 
understanding patients’ adjustment to epilepsy. 
Keywords: Epilepsy, diagnosis, meta-ethnography, qualitative, patient experience 
 
Highlights 
 Qualitative literature examining patients’ experiences of being diagnosed was 
systematically reviewed and synthesised using a meta-ethnography approach 
 Research from children, young adults, older adults, and relatives of people with 
epilepsy was assessed and a typical experience of being diagnosed with epilepsy is 
presented.  Complications and delays with diagnosis are commonly reported   
 The relationship with healthcare provider is of central importance to the experience 
of being diagnosed with epilepsy 
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1. Introduction 
The experience of living with epilepsy has been explored using a wide range of qualitative 
approaches such as a latent content analysis [1], a phenomological approach [2], and an 
ethnographic approach [3].  Researchers have been interested in the experiences of children 
with epilepsy [4], their parents [5], adolescents with epilepsy [1], young adults with epilepsy 
[6], and older adults with epilepsy [7].  Kerr, Nixon, and Angalakudit [8] conducted a 
systematic review of the qualitative literature looking at the impact of epilepsy on patients’ 
lives.  The authors reviewed 18 qualitative studies and devised a conceptual model of 23 
factors which they felt influenced the lives of children and adults with epilepsy.  Their model 
suggested that some factors directly affected patients' lives (such as the physical effects of 
epilepsy) while other factors had an indirect impact (e.g. a financial impact for adults due to 
the medication cost).  The authors also stated that many of the factors were shared amongst 
children and adults.  
Studies have found the experience of being diagnosed with epilepsy is important for patients 
however this has typically been explored via a broader qualitative investigation of epilepsy.  
For example, Sample et al. [9] found that the experience of being diagnosed was an important 
aspect when patients and their families considered how they had found support. Tonberg et 
al. [6] examined the experiences of young adults with regards to their knowledge of Sudden 
Unexpected Death in Epilepsy (SUDEP) and found that participants wanted this information 
but only after the initial diagnosis of epilepsy.  These studies suggest that the experience of 
being diagnosed has an impact on how people with epilepsy gain support and knowledge for 
the condition.   
A smaller number of studies have focused solely on the experience of being diagnosed with 
epilepsy.  Miller, Buelow, and Bakas [7] examined older adults’ experience of being 
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diagnosed with epilepsy and why there are often delays in diagnosing in this population.  
They found themes of ‘being dismissed’ and ‘frustration’ typically characterised their 
experiences.  Two qualitative examinations have examined the experiences of parents 
following their child’s diagnosis with epilepsy [5, 10].  Buelow and Shore [10] examined 
the experience in the context of identifying parental or healthcare ‘failures’ on the way to a 
successful diagnosis.   Nguyen, Pertini and Kettler [5] explored the coping processes of 
parents following their child’s diagnosis and noted themes of ‘loss of control’ and ‘emotional 
venting’.   
These studies helped identify areas of improvement and helped understand the adjustments 
people with epilepsy, or their caregivers, face after being diagnosed.  As a result of the 
specific populations examined, however, the general applicability of these findings may be 
somewhat limited. To the author’s knowledge there has been no attempt to synthesise the 
literature examining the experiences of being diagnosed with epilepsy. 
This systematic review produced a comprehensive account of the experience of being 
diagnosed with epilepsy by synthesising the qualitative research that has either directly or 
indirectly examined this experience.  The literature was critically appraised and the findings 
were synthesised to produce third order themes.  Using a meta-ethnographic approach [11] 
a set of themes was produced which explain the experience of an epilepsy diagnosis.   
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2. Aim 
To critically appraise and synthesise the qualitative literature that has examined the 
experience of being diagnosed with epilepsy. 
 
3. Material and Methods 
3.1 Method of synthesis 
The themes relating to the experience of being diagnosed with epilepsy were synthesised 
using a meta-ethnographic approach [11].  This process follows seven steps [12] and allows 
the translation of studies into one another, meaning that comparison is possible. The extant 
literature was systemically reviewed to find studies which have qualitatively examined the 
experience of being diagnosed with epilepsy, or which have investigated the experience as 
part of a qualitative investigation into epilepsy.  Those studies were then reviewed to select 
papers that provide themes that account for the experience of being diagnosed with epilepsy.  
Studies were first assessed by the researcher in terms of title and abstract.  Those studies 
which appeared suitable were then reviewed in full and reasons for subsequent exclusion 
detailed.  Included studies were then quality appraised. 
By following the meta-ethnographic approach as described by Atkins et al. [12], an overall 
understanding of the experience of an epilepsy diagnosis was then derived [13].  The main 
themes that were relevant to the experience of being diagnosed were entered into a table (see 
Table 1).  Themes were then contrasted and compared between studies to create third order 
themes that represented shared or compatible findings between studies.  This process 
involved exploring the individual themes of one study and comparing it with themes in other 
studies, in addition to the third order theme being created.  The resulting third order theme, 
although composed of pre-existing themes found in individual studies, expressed something 
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novel regarding the overall experience of being diagnosed with epilepsy.  The third order 
themes were then analysed to present a model that explained how they may be related to one 
another (this is known as a ‘line-of-argument’ synthesis [12]).   
 
3.2 Reflexivity 
The researcher was conducting qualitative research regarding clinicians’ views of discussing 
SUDEP at the time of this meta-ethnography.   
 
3.3 Search strategy 
MEDLINE (1990-present), EMBASE (1990 – present), PsychINFO (1990-present), and 
Web of Science (Core Collection 1990 – present) were searched using the EBSCO Host.  
The search was conducted on the 10th February 2016.   
The following search terms were separated by Boolean operators: 
1. epilepsy, OR seizures, OR tonic-clonic 
AND 
2. diagnos*, OR patient* experience*, OR patient* perspective*, OR patient* 
reaction*, OR personal experience 
AND 
3. Qualitative, OR qualitative analysis, OR qualitative research, OR content analysis, 
OR thematic analysis, OR grounded theory, OR Interpretative Phenomenological 
Analysis 
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Search terms varied to accommodate specific databases (see Appendix 2 for the search terms 
used for each database). 
 
3.4 Results of Search 
486 citations were produced as a result of using the above search terms.  169 of these were 
duplicates.  The remaining 317 articles were assessed by title, abstract and full text according 
to the following inclusion and exclusion criteria: 
 
3.5 Inclusion Criteria 
 Studies that directly examined the experience of being diagnosed with epilepsy. 
‘Being diagnosed’ referred to that process, or period of time, when an individual 
notices symptoms, seeks medical investigation, is informed of their condition and 
given information or advice regarding it, the subsequent immediate adjustment 
(<6 months following diagnosis), and thoughts on the process.  Included studies 
could investigate any part of this process 
 Studies were considered if they related to diagnosis as experienced by patients,  
caregivers, family members or partners 
 Any study that used a qualitative interview and analysis to examine patient 
experiences of an epilepsy diagnosis.  This included focus groups   
 Studies that examined all age ranges were considered 
 Studies which contained at least one theme relating to being diagnosed with 
epilepsy.  The theme had to be explored in an independent section of the Results 
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or Analysis section (i.e. it was not sufficient if the theme was a sub-theme of 
another theme) 
 Studies were included if the experience of being diagnosed occurred when a 
medical professional gave a diagnosis of epilepsy as a result of a neurological 
disorder (i.e. those studies which investigated experiences of people who were 
diagnosed with epilepsy as a result of ‘spirits’ were excluded)   
 Published in a peer reviewed journal 
 Published in the English language 
 
3.6 Exclusion Criteria 
 Studies that did not include a qualitative analysis 
 Studies which analysed the experience of living with a diagnosis of epilepsy (for 
inclusion they had to relate to the diagnostic process or experience) 
 Studies that explored the diagnosis of Non-Epileptic Seizures (NES) were not 
included due to the additional themes that are present for this population (such as 
‘resisting the diagnosis’ [14]) 
The results of this process are shown in figure 1.   
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Figure 1: Flowchart of search results 
 
4. Results 
Records identified through database 
searching 
(n = 486 ) 
Scree
n
in
g 
In
clu
d
e
d
 
Eligib
ility 
Id
en
tificatio
n
 
Records after duplicates 
removed 
(n = 317 ) 
Studies excluded based 
on: 
Title (n=248) 
Title and Abstract (n=32) 
 
Full-text articles assessed 
for eligibility  
(n = 37) 
Full-text articles excluded, 
with reasons  
(n = 26) 
No analysis of experience 
of diagnosis (n =14) 
Not peer reviewed journal 
(n=5) 
Experience of diagnosis 
only a sub section of a 
theme (n=2) 
Not in English (n=1) 
Not possible to isolate 
Epilepsy, multiple health 
conditions explored (n=1) 
Experience of diagnosis 
not given in the context of 
a neurological condition 
(n=1) 
Studies assessed as fatally 
flawed using quality 
appraisal tool (n=2) 
Full text studies assessed 
using Walsh and Downe’s 
(2006) framework  
(n =13 ) 
Studies included in meta-
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4.1 Quality appraisal 
While it is recognised that a checklist approach can be reductionist when quality appraising 
qualitative literature [15], Walsh and Downe [16] produced a checklist of quality criteria 
after assessing a range of critical appraisal materials.  Dixon-Woods et al. [17] also suggest 
five questions to assess if studies are ‘fatally flawed’.  All studies were firstly appraised 
using the Walsh and Downe [16] checklist (See Appendix 3).  The 8 studies which did not 
satisfy all 12 quality indicators were then assessed using the Dixon-Woods et al. [17] 
questions to ensure that potentially insightful analyses were not excluded on the basis of 
minor methodological flaws (see Appendix 4).  Two papers [18, 19] were excluded from the 
review on the basis of being fatally flawed (see Appendix 4). 
All of the included studies gave a clear rationale for the research.  None of the studies 
detailed a systematic approach to assessing relevant literature however, Sample et al. [9] 
included an in depth literature review justifying their phenomological approach.  Most of the 
studies did not justify why they chose their qualitative methodology.  The exception to this, 
again, was the Sample et al. [9] paper. 
It was common for papers to employ multiple researchers for coding and the analytic 
approach was deemed appropriate for most papers assessed.  The decision trail of all papers 
was clear to follow.  All papers used data to support their findings however the Miller, Bakas 
and Buelow [20] paper did not provide sufficient quotes to support interpretations.  
Sample et al. [9] discussed the relationship between the researcher and participants.  No 
other paper mentioned researcher reflexivity, however, there was evidence that papers had 
considered researcher influence on the research process and demonstrated self-awareness [4-
7, 21].     
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All papers demonstrated sensitivity to ethical issues and noted confidentiality procedures 
however it was felt that 2 papers could have considered providing support for participants 
who may have been distressed discussing their experiences [4, 22].  All papers discussed 
how their findings may contribute to existing theories and literature.   
Three of the studies were randomly selected for quality review and double rated by an 
independent reviewer.  Co-rater ratings are shown in Appendix 3.  Disagreements in rating 
were discussed and agreement reached by discussion.   
The characteristics of studies included in the meta-ethnography are shown in Table 1. 
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Table 1: Characteristics of studies 
Study (year) 
Country 
Method of 
analysis 
Participants Article themes relating to diagnosis 
Baca et al. (2015) 
[23] 
USA 
Thematic 
analysis 
37 individual interviews with parents (mean age 
= 41.3 (SD 7.3)) of children with epilepsy who 
had undergone resective epilepsy surgery (mean 
age at surgery 8.2 (SD 4.7)) 
Theme 1: Recognition ‘something is wrong’. 
Theme 2: Searching and finding: ‘a journey 
around the world and very circuitous’ 
Buelow and Shore 
(2006) [10] 
USA 
Cross case 
content analysis 
21 individual interviews with parents of children 
(ages 8-16) with epilepsy and significant learning 
problems 
Theme 3.1: The ideal trajectory of diagnosis. 
Theme 3.2: Failures in recognition and treatment 
Harden et al. 
(2015) [21] β 
Scotland 
Inductive 
thematic 
analysis 
27 individual interviews with young adults (aged 
18-29) with epilepsy 
SUDEP information giving and seeking. 
SUDEP information giving and reported 
behavioural change 
Tonberg et al. 
(2015) [6] β 
Scotland 
Inductive 
thematic 
analysis 
27 individual interviews with young adults (aged 
18-29) with epilepsy 
Theme 2: Knowing about SUDEP 
Theme 3: Impact of being told about SUDEP 
McNelis et al. 
(2007) [4] 
USA 
Qualitative focus 
group design 
4 focus groups were held with 2 groups of 
children (6 children with seizures  aged 7-14; 5 
children aged 9-15) and 2 groups of parents (6 
mothers and one father; 6 mothers and two 
fathers; ages not specified) 
Difficulties/struggles/problems. 
Need for information. 
Fears and concerns 
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Miller, Buelow and 
Bakas (2014b)* 
[7] USA 
Content analysis 20 individual interviews with older adults (aged 
60-80) with epilepsy 
Theme 1: Delayed diagnosis 
Theme 2: Non-delayed diagnosis 
Miller, Bakas and 
Buelow (2014a)* 
[20] 
USA 
Content analysis 20 individual interviews with older adults (aged 
60-80) with epilepsy 
Theme 1: Information 
Theme 5: Commitments 
Theme 6: Relationships 
Nair, Jack and 
Strohm (2016) 
[24] 
Canada 
Directed content 
analysis 
27 individual interviews with bereaved relatives 
(parent, sibling, spouse, or child aged at least 18 
years) of a person with epilepsy (18 were 
parents of children with epilepsy) 
Opinion on whether to discuss SUDEP. 
Method and timing of SUDEP discussion 
Nguyen, Pertini 
and Kettler 
(2015)[5] 
Australia 
Theory driven 
thematic 
analysis 
21 individual interviews with mothers of a child 
(aged 3-12) diagnosed with epilepsy  (diagnosis 
at least 6 months prior, but no longer than 2 
years prior to interview) 
The adjustment process. 
Cognitive appraisals. 
Coping behaviours 
Risdale, Kwan 
and Morgan 
(2003) [22] 
England 
No specific 
approach stated 
22 individual interviews with patients (aged 17-
83) who had attended a nurse run epilepsy clinic 
Challenges for patients 
Sample et al. 
(2006) [9] 
USA 
Phenomological 
approach 
4 focus groups comprising 31 participants ( 7 
aged 0-21, 24 aged 22-64), either people with 
epilepsy or family members 
Theme 1: Searching, hoping, finding, trying, 
searching 
*Same sample studied, different focus of study,  
β Same sample studied, same focus of study, alternative conclusions and themes considered.  
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The article themes relating to diagnosis were then expanded and unpacked in a subsequent 
column – noting specific components of the article theme and illustrative direct quotes 
from participants.  Discussion based themes that related to the article themes were also 
noted (Atkins et al. [12] refer to these as ‘2nd order themes’).  Article and discussion 
themes were compared across papers and through the process of constant comparison, third 
order themes were developed.  An illustrative example of this is shown for one of the 
papers in Appendix 5.  
The meta-ethnography produced the following third order themes: 1) Initial onset 2) 
Diagnosis complications 3) Relationship with Healthcare Staff 4) Information (sources, 
content and ownership) 5) Time to Process the Diagnosis 6) Role Change and Adjustment.  
The contribution of individual papers to the generated themes is shown in table 2.  Each 
theme is discussed in detail below. 
 
4.2 Initial Onset 
The experience of being diagnosed with epilepsy begins by noticing the symptoms of 
epilepsy.  Initially, patients may not seek medical attention as symptoms do not interfere 
with their daily activities or work [7].  
‘I was still working at the time…it was low on my to-do list’ [7, p6] 
Some of the same study’s participants were embarrassed about their symptoms and only 
sought medical attention when their relatives persuaded them: 
‘my daughter thought I was having a stroke…finally they convinced me to go’ [7, 
p7]    
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The above quote highlights another feature of the initial onset in that there is often confusion 
about symptoms and what they are experiencing, however, there is a recognition that 
something is wrong, and it is serious [9, 23]: 
‘I knew there was something wrong with me. I did not know what.’ [9, p653] 
This recognition is shared by relatives: 
‘I didn’t know what was going on and I had no idea.  I just knew it was an 
emergency’ [23, p825] 
‘…he started putting his head back. I thought he was tired and I laid him on the 
couch and he had a grand mal seizure’ [10, p442] 
Buelow and Shore [10] identify that the epilepsy symptoms of their participants’ children 
were often first identified by a healthcare professional or teacher.   
  
20 
 
Table 2: Contribution of papers to 3rd order themes  
 
 
Initial Onset Diagnosis 
Complications 
Relationship with 
Healthcare Staff 
Information (sources, 
content and 
ownership) 
Time to Process the 
Diagnosis 
Role Change and 
Adjustment 
Baca et al. (2015) [23] 
USA 
Recognition – 
something  is wrong 
 Searching and Finding  Searching and Finding Searching and Finding 
Buelow and Shore 
(2006) [10] 
USA 
The ideal Trajectory 
 
Failures in recognition 
and treatment 
The ideal Trajectory 
 
Failures in recognition 
and treatment 
Failures in recognition 
and treatment 
   
Harden et al. (2015) 
[21] β 
Scotland 
  SUDEP information 
giving and seeking 
SUDEP information 
giving and seeking 
SUDEP information 
giving and seeking 
SUDEP information 
giving and seeking 
Tonberg et al. (2015) 
[6] β 
Scotland 
  Knowing about 
SUDEP 
Knowing about 
SUDEP 
Knowing about 
SUDEP 
 
Impact of being told 
about SUDEP 
 
McNelis et al. (2007) 
[4] 
USA 
 Difficulties/struggles/pr
oblems 
Difficulties/struggles/pr
oblems 
Difficulties/struggles/pr
oblems 
Need for information 
 
Fears and concerns 
Difficulties/struggles/pr
oblems 
 
Need for information 
 
Fears and concerns 
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Miller, Buelow and 
Bakas (2014)* [7] USA 
Delayed diagnosis 
 
Non-delayed diagnosis 
Delayed diagnosis 
 
Non-delayed diagnosis 
    
Miller, Bakas and 
Buelow (2014)* [20] 
USA 
   Information  Commitments 
 
Relationships 
Nair, Jack and Strohm 
(2016) [24] 
Canada 
  Method and timing of 
SUDEP discussion 
Opinion on whether to 
discuss SUDEP 
 
Method and timing of 
SUDEP discussion 
Method and timing of 
SUDEP discussion 
Opinion on whether to 
discuss SUDEP 
Nguyen, Pertini and 
Kettler (2015)[5] 
Australia 
   Coping behaviours. The adjustment 
process 
The adjustment 
process 
 
Cognitive appraisals 
 
Coping behaviours 
Risdale, Kwan and 
Morgan (2003) [22] 
England 
   Challenges for patients Challenges for patients Challenges for patients 
Sample et al. (2006) 
[9] 
USA 
Searching, hoping, 
finding, trying, 
searching 
Searching, hoping, 
finding, trying, 
searching 
Searching, hoping, 
finding, trying, 
searching 
Searching, hoping, 
finding, trying, 
searching 
  
*Same sample studied, different focus of study 
β Same sample studied, same focus of study,  alternative conclusions and themes considered.   
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4.3 Diagnosis Complications 
Unfortunately, it would appear that receiving an incorrect or delayed diagnosis is common 
and a shared experience across children, adults and older adults [4, 7, 9, 10, 22].   
 ‘The first one [neurologist] misdiagnosed me for 3 years’ [9, p653] 
‘Every time I went back they would diagnose me with something different or say it 
was something I already had…so it took almost a year and a half.’ [7,p6] 
This is distressing for patients and their families and in addition to the potential financial 
cost to American patients [7], it may also result in inappropriate treatment [10].  Parents 
describe ‘a feeling of desperation to get a diagnosis’ for their child [23, p825]. 
The reasons for delays are varied but include people with epilepsy and their families being 
unfamiliar with symptoms [10], being reluctant to seek treatment [7], and healthcare staff 
being unfamiliar with signs and symptoms of epilepsy [7, 9, 10].  Two studies suggest that 
those of a lower socio-economic status tend to wait longer for a successful diagnosis [7, 10]. 
Factors were identified across studies that lead to a more timely diagnosis.  Children under 
the care of a physician for another medical condition were identified as receiving a successful 
diagnosis [10] and patients who exhibit more classical symptoms of seizures were more 
readily diagnosed than those who exhibit more ambiguous signs [7]. 
 
4.4 Relationship with Healthcare Staff 
The relationship with healthcare staff is of fundamental importance to the experience of 
being diagnosed with epilepsy and the majority of studies included themes or quotes that 
reflected this [4, 6, 9, 10, 21, 23, 24].  During the initial stages of the diagnosis, some patients 
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feel that healthcare staff are dismissive of their concerns or do not believe their descriptions 
[4, 7, 9, 10, 23]:   
‘I didn’t say anything to the doctors or anything at that point because I [didn’t 
think] I’d be believed. [I thought] I’d just be [considered] a hysterical mother.’ 
[10, p443] 
‘He said my symptoms had to be hormonal…and the last time I saw him he said 
maybe I was…cursed’ [7, p6] 
‘The doctors questioned whether or not I was making this up’ [9, p653] 
Staff may be reluctant to form relationships: 
‘I had difficulty talking to the doctor and nurses; I did not feel part of the team; the 
doctors and nurses never talked to my child either’ [4, p198] 
In contrast, patients note how helpful a positive relationship with healthcare staff can be to 
the experience of being diagnosed: 
‘The seizure clinic down at [a specific hospital]…I can call 24 hours a day, and 
they have somebody there to answer my questions.  And that helps a lot.’ [9, p654] 
Additionally, patients and family members note that the relationship with the neurologist, 
physician or epilepsy nurse specialist determines who should relay information about 
SUDEP risk [6, 21, 24].  And that it is important that clinicians discuss SUDEP because if 
not: 
‘it could create a bit of mistrust’ [21, p234] 
Trust appears to be a crucial component of the relationship formed with professionals: 
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‘the big thing is finding somebody who you can trust, who you’re comfortable with, 
who [the child] is comfortable with, who will respond to your questions…’ [4, 
p198] 
 
4.5 Information (sources, content and ownership) 
Two studies suggested that people can find it difficult to get enough information about 
epilepsy [4, 20] and this may cause embarrassment when explaining the condition to others 
[20].  People with epilepsy may also forget to ask important questions when speaking to their 
clinicians [22]. 
Information is valued most from people, rather than leaflets, books or the internet [20, 21, 
24].  This is because an ‘open dialogue can occur and that questions can be addressed’ [24, 
p23].  Information from books or the internet may also be confusing for older adults with 
epilepsy [20].  People commonly search for information after being diagnosed however, and 
the internet can be a useful resource for this [9].  Information is appreciated when it comes 
from other people with epilepsy, or parents of children with epilepsy [5, 20].  This is reported 
to be ‘informative and reassuring’ [5, p32] and the same researchers suggest these 
opportunities should be facilitated.  McNelis et al. [4] note the contribution that general 
health professionals and school staff make in providing information about epilepsy and 
suggest that increasing the knowledge of epilepsy amongst these staff groups would be a 
valuable clinical intervention.   
Patients want to be informed about SUDEP at or around the time of diagnosis [6, 21, 24].  
Moreover, patients feel they have a right to this information. 
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‘you have a right to know…I really kind of resent the idea that a doctor in 
particular would not share that information because he had some personal feelings 
about ‘that’s not good for her [to know about SUDEP]’  [24, p22] 
 
4.6 Time to Process the Diagnosis 
People with epilepsy and their families need time to process the diagnosis [4, 6, 21, 22-24].  
This is for two reasons: firstly, there is too much information to take in [4, 23, 24].  Some 
participants noted it was: 
 ‘Like an avalanche of information coming at us’ [23, p825] 
 ‘I think it’s a learning curve process on a need-to-know basis.  If you get too much 
information too fast, you get overwhelmed and confused, you don’t know the 
jargon’ [4, p199]. 
This indicates that learning about epilepsy can be a cognitively demanding process.  
Secondly, time is required to process the emotional impact of the diagnosis [5, 6, 21, 22].  
When asked about when they would like to receive information about SUDEP one 
participant answered: 
‘The [session] after [diagnosis]…cos getting epilepsy is a bit of a shock to 
everybody never mind finding out that you could die from it’ [6, p101] 
The emotional impact of receiving the diagnosis may be less for older adults than for younger 
adults: 
‘I think because all these years I have had to cope with a cardiac problem, it’s just 
something more that I have taken on board, you know’ (64 year old woman, [22, 
p71]) 
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4.7 Role Change and Adjustment 
After receiving a diagnosis of epilepsy it is common for people to report a role change with 
family members.  Parents of a child diagnosed with epilepsy often become advocates [4, 5, 
23].  Nguyen, Pertini and Kettler [5] describe this as having to ‘relentlessly negotiate for 
their child’s needs’ [5, p31].  
Other role changes were noted: 
‘We’ve been together 40 years…real independent.  But now…[my husband] hovers.  
I went from being wife…to child’ [20, p29] 
There is a recognition that parents may become more protective of their child if they learn 
about SUDEP [24].  Positive role changes are also identified: ‘mothers [take] pride in feeling 
that they were well placed to offer advice to others’ [5, p29]. 
Following the initial reaction to the diagnosis, people adjust to the experience of being 
diagnosed with epilepsy [5, 20, 21].  Some of the older adults in Miller, Bakas and Buelow’s 
[20] study adjusted to the diagnosis by withdrawing from work or volunteering 
commitments: 
 ‘I went from part time to really part time’ [20, p28] 
In contrast, the parents in Nguyen, Pertini and Kettler’s [5] study indicate that things get 
better following the diagnosis and the authors identify a number of cognitive strategies which 
facilitate this change.   
‘it does get better…it’s not as traumatic as when it first started’ [5, p27] 
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Harden et al. [21] note that discussions about SUDEP appear to have little influence on their 
participants’ behaviour and this was a way of adjusting to the knowledge they could die from 
epilepsy. 
Figure 2 shows a diagrammatic representation of the third order themes.  The diagram 
represents the temporal features of the themes identified and the dominance and influence 
of the ‘relationship with healthcare staff’ is emphasised. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Relationship of the themes 
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5. Discussion 
Some patients do not report initial symptoms of epilepsy either because they are 
misidentified, or because they fear an epilepsy diagnosis will cause them inconvenience.  
Consequently, relatives, and healthcare or school staff play an important role in noticing 
initial epilepsy symptoms and prompting action.  The results of this meta-ethnography 
support the recommendation of McNelis et al. [4] that general healthcare and school staff 
should be aware of epilepsy symptoms.   
The ubiquity of diagnosis complications across age ranges is a prominent theme.  While 
there may be factors that make epilepsy diagnosis with older adults more complicated [7], 
this meta-ethnography would suggest that complications or delays in diagnosis are not 
unique to this population. 
The information patients receive about their condition is found to be wanting in some 
respects.  Although Risdale, Kwan and Morgan [22] note that patients forget to ask important 
questions when they see their physician, one may ask if that burden should lie solely with 
the patient, and what the presence of such cognitions indicates about the quality of the 
patient-doctor relationship.  The fact that patients value information from other patients or 
relatives (and that they value providing that information) suggests that Nguyen, Pertini and 
Kettler [5] are correct in suggesting that even informal opportunities to do so should be 
promoted. Research has indicated that parents report a reduction in overall stress when they 
have an opportunity to receive information about their child’s chronic condition from parents 
in a similar situation [25].  The results of this meta-ethnography would support this finding 
and may suggest that a similar desire for support is present in adult patients living with 
epilepsy. 
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Time is needed to process the experience of being diagnosed.  Tonberg et al. [6] note that 
the appointment following diagnosis may be appropriate for information regarding SUDEP.  
This may suggest that as few as two appointments may be sufficient for time to process the 
information. Time is also required to process the emotional impact of the diagnosis however 
the impact may be less for older adults.   
The role changes following diagnosis were rarely regarded as positive.  It may be beneficial 
to consider what causes some patients to withdraw socially [20] and others to feel that ‘it 
does get better’ [5, p27].   
 
5.1 Centrality of the Relationship With Healthcare Staff 
An important finding of this meta-ethnography has been the centrality of the relationship 
with healthcare staff to all of the themes relating to the experience of being diagnosed with 
epilepsy (apart from the initial onset).  The relationship appeared to either positively or 
negatively influence the other themes found.  The relationship with healthcare staff often 
appeared to ameliorate or exacerbate the impact of diagnosis complications and affected 
patients’ perceptions of the information they received.  The relationship with the healthcare 
staff may also influence the required time to process the diagnosis (informationally and 
emotionally) and in regards to how patients adjust to their new roles.  Given the importance 
placed on the relationship in other areas of the diagnosis, this may suggest an avenue for 
intervention.   
The relationship with healthcare staff is important not just because it affects the other third 
order themes of the experience of being diagnosed – it is an important factor in its own right.  
Patients value the relationship with healthcare staff as a source of trust, understanding and 
support.  This is not a unique finding with regards to how patients cope with chronic 
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conditions.  Previous research has identified that information seeking from healthcare 
professionals is a coping strategy to gain control over an unpredictable condition [26] and 
the positive relationship provides an additional sense of support [27].  This systematic review 
supports these findings and in so doing so, contributes to the literature suggesting people 
with long term health conditions find great value in the relationship with their healthcare 
provider. 
It is interesting to note the parallels to Kerr, Nixon, and Angalakudit [8] which noted the 
concerns of patients living with epilepsy were relationships with friends, partners and 
families.  It has been evident for some time that adjustment to chronic illness is a multi-
factorial process [28]. This meta-ethnography has highlighted the importance of 
relationships with healthcare staff as a factor which may exert a strong influence on the 
experience of being diagnosed with epilepsy and the subsequent adjustment to the condition.  
 
5.2 Limitations 
One of the strengths of this study is that studies on unique populations contributed to themes 
which could be translated to children, adults and older adults (Table 2).  This suggests that 
it is possible to conceive of ‘a diagnosis experience’, despite the variety of individuals and 
contexts epilepsy presents in.  However, it may be useful to explore if the themes identified 
apply equally to all patient groups.  For example, evidence that specific populations 
commonly wait longer for diagnosis [10] may suggest this is not the case.  In a similar regard, 
particular themes relating to the experience of being diagnosed will have been influenced by 
the country and culture of the studies involved.  The potential cost implications of a delayed 
diagnosis for American patients has already been noted [7], however, there may be additional 
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impacts on health care delivery between privatised and public health care systems (e.g. 
access to resources, or use of care pathways).   
It is worth acknowledging the lack of qualitative research focusing on children’s experiences 
of being diagnosed with epilepsy.  This is in contrast to the greater amount of qualitative 
research conducted on parental views of the diagnosis.  The model presented in this research 
is derived from mainly adult and older adult experiences (both as patients and as relatives of 
the person with epilepsy).  It is not clear to what degree the themes found in this model 
would apply to children and young people.  
It is notable that there are two sets of papers used in this review which share a data set [7 
and 20; 6 and 21].  In this systematic review these four papers account for quite an extensive 
range of conclusions so it is important to recognise the relatively small sample size of 
participants used (20 participants [7, 20] and 27 participants [6, 21] respectively).  This also 
results in a single, potentially skewed data set, being analysed twice.  Given this, there is 
also a possibility that the super ordinate themes found in this systematic review are similarly 
affected.  While this does not invalidate the conclusions reached in these papers, or the 
systematic review, the opportunity exists to explore these findings in the wider population.   
As noted in the reflexivity section 3.2, the researcher was conducting research on 
clinicians’ experiences of discussing SUDEP at the time of conducting this meta-
ethnography.  It may be that the results of this research and the researcher’s background in 
psychology influenced the interpretation of this review.   
 
5.3 Conclusion 
Despite the extant qualitative research focusing mainly on the experiences of being 
diagnosed with epilepsy in specific populations, it appears that themes are shared across 
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populations and experiences and a conceptual model was presented to account for this.  
Initial symptoms are often spotted by others and diagnosis complications and delays are 
common.  Patients require time to process the diagnosis in terms of informational load and 
emotional impact.  Information is valued more from people (including fellow people with 
epilepsy or their relatives) rather than leaflets or the internet.  Role changes following the 
diagnosis are usually considered as negative.  The relationship with healthcare staff is of 
central importance not only in relation to the experience of diagnosis, but also as being a 
source of trust and support. 
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Plain English Summary 
 
SUDEP refers to Sudden Unexpected Death in Epilepsy.  It is not known 
precisely why SUDEP occurs, however people with epilepsy who have a higher 
number of seizures are at a higher risk of death (although this is a rare event, 
occurring in only 1/1000 people with epilepsy).  Research has shown that 
American clinicians can be reluctant to discuss SUDEP with their patients in 
some cases (Miller, Young, Friedman, Buelow & Devinsky, 2014).  Research 
in the UK has also indicated that clinicians may not be regularly informing their 
patients about the risks of SUDEP.  As a result of a Fatal Accident Inquiry 
(FAI) in 2010, clinicians working in Scotland were advised that they must 
inform their patients about the risk of SUDEP following a diagnosis of epilepsy 
except in rare circumstances.  This research examined how clinicians have felt 
discussing SUDEP in this context. 
 
Aim 
 
To understand the experiences of neurologists working in Scotland who have 
discussed SUDEP with their patients.   
 
Methods 
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Six Neurologists and four Neurology Registrars who had been working in 
Scotland for at least one year were recruited.  The researcher used a thematic 
analysis (a type of qualitative analysis) to explore the interviews and identify 
themes that accounted for their experiences. 
 
Results 
 
Five themes were identified: Clinicians use a ‘SUDEP protocol’ – this was 
proposed to be a standardised way of talking about SUDEP; The FAI has 
diffused into practice through meetings and discussions with colleagues; 
Clinicians feel ambivalent about discussing SUDEP with patients who are 
newly diagnosed with epilepsy; Clinicians think that patients will be distressed 
about hearing about SUDEP, however it is very rare for patients to react badly 
to the news; Clinicians feel the pressure of needing to discuss SUDEP hinders 
effective communication with their patients. 
 
Conclusion 
 
This research suggested that the FAI has influenced clinicians working in 
Scotland and the majority now routinely discuss SUDEP with newly diagnosed 
epilepsy patients.  There is concern, however, that the conversations may have 
an emotional impact on patients, and that the information patients need to know 
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about SUDEP is not conveyed appropriately because of the impact of the 
epilepsy diagnosis.  Similar to findings in America (Miller et al., 2014), 
clinicians value a sense of clinical autonomy.  Clinicians feel pressure to 
discuss SUDEP after an epilepsy diagnosis and they are concerned that patients 
may fail to fully comprehend the implications of this information, or that the 
information may be anxiety inducing.  This research may be useful for future 
guideline development.   
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Abstract 
Since the findings of a Fatal Accident Inquiry (FAI) in 2010, clinicians working in Scotland 
have been advised to discuss the risk of Sudden Unexpected Death in Epilepsy (SUDEP) 
with patients immediately or soon after a diagnosis of epilepsy is made.  A thematic analysis 
was used to describe the experiences discussing SUDEP of 10 clinicians (six Consultant 
Neurologists and four Neurology Registrars) working in Scotland.  Five themes were found: 
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Clinicians employ a ‘SUDEP protocol’, suggesting there is a standardised way of discussing 
SUDEP with patients and all clinicians routinely discuss SUDEP with newly diagnosed 
epilepsy patients; The FAI has diffused into practice through meetings and discussions with 
colleagues; ‘Breaking Good News’ refers to the ambivalence clinicians feel about discussing 
SUDEP; ‘Falsely anticipating anxiety’ refers to clinicians anticipating a distressed response 
from patients despite this very rarely occurring; Clinicians suggest that ‘pressure hinders 
effective communication’ to patients – suggesting that the pressure to discuss SUDEP early 
after diagnosis may have an emotional impact on patients and affect the amount of 
information they can take in.  Implications for guideline development are discussed. 
 
Highlights 
 A qualitative examination of neurologists’ experiences discussing SUDEP 
 Clinicians state they are regularly discussing SUDEP with patients who have newly 
been diagnosed with epilepsy 
 Clinicians feel ambivalent about discussing SUDEP despite indicating the 
experience is not distressing for themselves, or apparently for their patients 
 
Keywords: SUDEP, epilepsy, qualitative, thematic analysis, neurology practice, breaking 
bad news 
 
1. Introduction 
It has been argued that in the 20th century the risk of death due to epilepsy became minimised 
then denied by the medical community [1].  It was not until 1996 that the term ‘Sudden 
Unexpected Death in Epilepsy’ (SUDEP) was proposed.  SUDEP refers to the death of a 
patient with epilepsy which appears to occur without a specific reason [2].  Death can occur 
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with or without the presence of a seizure (but not due to status epilepticus), be witnessed or 
un-witnessed, and the term excludes deaths that have occurred due to toxicological or 
anatomical reasons [3].   The mechanism by which SUDEP occurs is not fully understood 
[4] however patients can take actions to lower their risk.  Chiefly amongst these, people are 
encouraged to ensure their seizures are well controlled (i.e. occurring at a minimal rate) by 
adherence to anti-epileptic medication [5, 6].  Other risk factors for SUDEP include: having 
a greater yearly frequency of generalised tonic-clonic seizures, higher rates of nocturnal 
seizures [7], and an early age of onset (a higher SUDEP risk occurs in those diagnosed before 
the age of 16 [8]).  SUDEP is a rare event for people with epilepsy, with an incident rate of 
around 1/1000 [9].     
NICE guidelines specify that following a first seizure, patients should see a specialist in the 
management of epilepsy [10].  Discussions regarding SUDEP with patients should contain 
‘tailored information’ that ‘takes account of the small but definite risk of SUDEP’ [10, 
Section 1.3.13, p16] however, access to this information should depend on the certainty of 
the diagnosis [10].  The American Epilepsy Society and the Institute of Medicine 
recommend that the increased risk of death associated with epilepsy be disclosed to patients 
[11, 12].  
Harden, Tonberg, Chin, McLellan, and Duncan [13] interviewed adults (aged 18-29) and 
found they were keen to have a SUDEP discussion with their clinician preferably during the 
session they are diagnosed with epilepsy, or soon thereafter.  Nair, Jack, Meaney, and Ronen 
[14] conducted focus groups with parents of children with epilepsy and found that they also 
wished to be informed about SUDEP during their first discussion of epilepsy.  Additionally, 
Nair et al. [14] noted that parents were ‘emphatic’ that they should not first learn about 
SUDEP from the internet or an information leaflet. Bereaved relatives of patients who have 
died from SUDEP are keen that SUDEP risk is discussed with patients and their relatives at 
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the time of diagnosis, however, they noted that this should be done on a case by case basis 
with an understanding that the news may have potentially negative consequences [15]. 
Despite the wishes of patients and the guideline suggestions, the literature has identified that 
clinicians are not regularly having SUDEP discussions with their patients.  Morton, 
Richardson and Duncan [16] analysed 387 questionnaires when surveying the practice habits 
of UK based neurologists.  Around 70% discussed SUDEP with ‘very few’ or ‘none’ of their 
patients.  Similarly, of 1200 American and Canadian neurologists surveyed, less than 7% 
reported they were routinely discussing SUDEP with all patients [18].  Miller, Young, 
Friedman, Buelow, and Devinsky [19] used a qualitative approach to understand the practice 
of American clinicians (Epileptologists, Neurologists, and Advanced Practice Nurses) when 
discussing SUDEP.  A theme of ‘moral accountability’ was present when clinicians 
expressed a reluctance to discuss SUDEP with their patients if they felt it was ‘morally 
wrong to give information about a complication that is poorly understood and difficult to 
prevent’ [19, p40].  Clinicians wanted to wait until rapport was built with their patients 
before discussing SUDEP and there was a reluctance to discuss SUDEP if all treatment 
options had been tried.     
 
Friedman et al. [18] reported that a perceived negative reaction to discussions of SUDEP 
were common in their US and Canadian sample of Neurologists.  This reaction is perhaps 
understandable given the findings of research on breaking bad news (BBN).  Clinicians may 
fear a negative response from patients during BBN experiences, and clinicians can feel 
responsible for the bad news [20, 21].  BBN is especially difficult when there are limited 
options for treatment [22] or if there is a feeling of inadequacy treating an uncontrollable 
disease [23].  It is interesting to note that the studies which have examined patients’ 
responses to hearing about SUDEP have not indicated they experience an unduly negative 
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reaction [13, 24].  The young adults interviewed in Scotland wanted to hear about the risk of 
SUDEP around the time of diagnosis, and the knowledge that SUDEP may occur led to short 
lived anxiety which did not appear to influence their health behaviours.  The researchers 
suggested that the patients they interviewed wanted to find out about SUDEP primarily 
because they had a right to know about this information - not because they could potentially 
use the information to lower their SUDEP risk [24]. 
Scottish guidelines issued in 2005 suggested that information about SUDEP was to be 
considered ‘essential’ to provide to patients upon diagnosis of epilepsy [25].  Moreover, 
Neurologists who work in Scotland are likely to be aware of a Sheriff-led Fatal Accident 
Inquiry (FAI) into the deaths of Erin Casey and Christina Fiorre Ilia in 2010 [26].  This 
established that two Scottish Health Boards were at fault for not informing these patients, 
and their parents, of the risk of SUDEP.  Following an FAI, the Sheriff will make 
recommendations as to how to prevent a similar situation occurring in the future.  The 
Scottish Government website states that ‘the responsibility for learning any lessons which 
come out of the inquiry, and for implementing any recommendations made, lie with those 
who have responsibility for managing the systems in question’ [44].  One recommendation 
was the ‘vast majority’ of patients should be informed about SUDEP upon being diagnosed 
with epilepsy or it should be recorded as to why this did not take place.  Health Boards can 
therefore expect a SUDEP discussion to be held with the vast majority of patients following 
an initial diagnosis.  The impact of the medical guideline developments and the FAI on the 
practice of discussing SUDEP is not yet clear.  Research in 2006 suggested that clinicians in 
the UK were not regularly discussing SUDEP with their patients and this was after the SIGN 
guidelines had been updated in 2005 [16].  In 2013, Waddell, McColl, and Turner [17], in a 
retrospective analysis of patients who attended a specialist epilepsy clinic in Scotland, found 
that a documented discussion of SUDEP occurred in only 4% of the 345 case notes 
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examined.  This may suggest that the FAI in 2010 had a limited impact on the practice of 
discussing SUDEP for clinicians working in Scotland.  It is important to note, however, that 
the researchers included chronic epilepsy patients in their study and they may not have found 
a high rate of SUDEP discussions as the Sheriff’s recommendation to discuss SUDEP 
pertained to newly diagnosed patients only.  Research in 2015 with young adults in Scotland 
who had been newly diagnosed with epilepsy indicated they had uniformly been informed 
about SUDEP after diagnosis [13, 24].       
 
Interestingly, Scottish guidelines were updated again in 2015 and the message regarding the 
need to discuss SUDEP has changed [27].  The guidelines note that there is not enough 
evidence to suggest that informing patients about the risk of SUDEP will improve their 
adherence to medication and the guidelines advise that: ‘Counselling about the risks of 
sudden unexpected death in epilepsy should be considered for patients with epilepsy at an 
appropriate time for the patient and by an appropriate healthcare professional’ [27, p55]. 
This is clearly less imperative than the former guidelines issued in 2005.  The updated 
guidance may be a recognition that a SUDEP discussion following a diagnosis of epilepsy 
may not always be necessary or useful.   
There is an understanding that clinicians in Scotland have been in a unique position where 
an FAI has recommended them to have SUDEP conversations with patients following 
diagnosis.  It is not clear as to how Neurologists have interpreted and understood these 
recommendations and the obligation they feel to practice in this manner.  This research was 
interested in knowing how this has affected their practice and experience of SUDEP 
discussions.  This study was interested in adding to the literature which has assessed if 
SUDEP discussions are routinely taking place.  Given the recent findings that patients do 
not appear to be overtly distressed learning about SUDEP [13, 24], this study was interested 
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in understanding clinicians’ perceptions of their patients’ feelings and if they felt the 
information about SUDEP would encourage medication adherence.   Potential methods of 
support to facilitate SUDEP discussions between Neurologist and patient were also explored.  
This research may provide a useful comparative model for countries, health boards or 
organisations that are considering guideline recommendations for how and when SUDEP is 
discussed with patients. 
 
1.2 Aim 
To explore the experiences of Neurologists when discussing SUDEP with their patients and 
develop themes to account for these.   
The objectives of the research were to understand how the participants discussed SUDEP; 
how the participants felt when discussing SUDEP (including their thoughts on the impact of 
the discussion on patients); how they classified good and bad experiences when discussing 
SUDEP; methods of support utilised or envisioned; feelings about the legal/legislative 
context to discuss SUDEP and reflections on the practise; as well as assessing if similar 
themes identified in previous research were present [19].   
 
2. Material and Methods 
 
2.1 Participants 
The views of clinicians with a range of experience were sought, therefore Consultant 
Neurologists and Registrar Doctors were considered for inclusion in the research (typically, 
Registrar Doctors who specialise in Neurology will have at least 4 years of clinical training 
in neurology before becoming a consultant).  Given the recommendations that 6-12 
participants are sufficient for understanding common perceptions and experiences among a 
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group of relatively homogenous individuals [28], a minimum participant sample size was set 
at six participants.  
 
2.2 Recruitment and Interview Procedures 
The researcher attended a departmental educational meeting of the West of Scotland 
Neurology Service (a group of Consultant Neurologists and Registrar Doctors) in November 
2015 to present information about the research and recruit participants directly.  Potential 
participants were asked to sign up to the research if they were interested and an email was 
sent to the group’s list serve following the meeting seeking interested participants.  A set of 
questions were devised to help guide discussions with participants (Appendix A).  These 
questions were developed by examining the previous literature and by consulting with the 
Consultant Neurologist Field Supervisor.  Supplemental questions were asked based on the 
content of the interviews.  The interview was trialled with the Consultant Neurologist Field 
Supervisor before conducting interviews with the participants. 
Participants were contacted to arrange interview times and the researcher then conducted 
face to face interviews with participants at their place of work (with one interview being 
conducted by phone).  Participants were given a Participant Information Sheet (Appendix 
B) and informed consent was obtained before commencing the interview.   
 
2.3 Qualitative Design and Research Procedures 
A thematic analysis explored the experiences of clinicians when discussing SUDEP with 
patients.  This particular method was chosen as previous research had used a similar 
approach to investigate the experiences of American clinicians’ practice of discussing 
SUDEP [19] and it was felt a comparison of practice would be useful.  Additionally, given 
the focus of the research was in describing experiences and practice of the population 
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studied, a thematic analysis was judged to be more appropriate rather than an analysis which 
could provide a theory to explain an experience (e.g. grounded theory) or an analysis which 
is focused more on accounting for a particular individual’s experience (e.g. Interpretative 
Phenomological Analysis) [30].  The researcher used an inductive approach to analysis [29] 
as a pre-existing coding frame was not used and themes were constructed from the data, 
rather than from pre-existing theory.  Themes were primarily identified using a semantic 
approach; taking themes from the explicit statements of participants.    
The research procedure was conducted in line with Braun and Clarke’s [29] proposed six 
phases of thematic analysis.  This six stages were as followed: 1) After conducting each 
interview, the interviews were transcribed then read and checked with the audio recording 
for accuracy.  Through this process the researcher noted down initial themes and ideas and 
became familiar with the data.  2) The data was then coded line by line (see Appendix C for 
a sample of coded transcript).  Codes accounted for ‘implicit concerns as well as explicit 
statements’ [30, p50].  Codes were also generated for interesting features of the data (i.e. a 
code representing a group of other codes, or some broader aspect of the data).  It was an aim 
that the generated codes ‘evoke the data’ [31].  It was possible, and quite common, for a line 
of text to have more than one code assigned to it.  During this stage, themes of interest began 
to gradually form and the researcher kept a note of themes that could be explored with 
subsequent and future transcripts. The research supervisor (a Clinical Psychologist) also 
coded and commented on an interview data set.  3) As coding progressed, codes were more 
readily synthesised into themes that were shared between clinicians or accounted for an 
aspect of the experience that explained a ‘patterned response or meaning within the data set’ 
[29, p82].  Therefore, initial transcripts tended to have more codes assigned, whereas later 
transcripts were more likely to be repeating, or adding to existing themes.  A list of all themes 
was collated and these were clustered into overall themes that could explain the themes found 
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(Appendix D shows the document that was used to track, alter and arrange these emerging 
themes).  4) The individual and overall themes were checked with the codes of transcripts, 
and with the data set as a whole to check for consistency or discrepancy.  5) As this process 
of checking progressed, overall themes were defined to best account for the data and offer a 
narrative that could explain the data set.  Often this involved altering the composition of 
overall themes by adding or subtracting individual themes accordingly.  6) The final analysis 
was expressed with quotes from participants being selected to illustrate the themes found.  
This offered a final opportunity to check the coherence and explanatory power of the 
analysis. 
 
2.4 Data Saturation 
After the 8th interview no novel themes were found indicating that data saturation had 
occurred.  
 
2.5 Reflexivity 
Blumer [32] describes the assumptions and prior knowledge of a researcher as ‘sensitizing 
concepts’.  Therefore, the researcher’s background as a Trainee Clinical Psychologist is 
relevant.  Issues of support and the psychological impact of breaking bad news were areas 
of interest to the researcher.  The researcher’s own thoughts and interpretations were 
monitored by keeping a reflective log throughout the research process.  Rather than 
considering the researcher’s opinions as hindering the research, it is acknowledged that these 
are fundamental to the process and in deriving themes.  Of particular relevance may have 
been the focus on anticipation of distress or anxiety in patients. 
 
2.6 Settings, Equipment and Materials 
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The researcher used a digital voice recorder to record interviews and data was stored on 
secure NHS servers.   
 
2.7 Ethical Issues 
Data was anonymised and stored in line with the University of Glasgow’s policy on 
confidential data (http://www.gla.ac.uk/media/media_180727_en.pdf).  Anonymity was 
preserved by redacting location and other identifying information from transcripts. Approval 
for the study was received from the Research and Development team in NHS Ayrshire and 
Arran and ethical approval obtained from the school of Medical, Veterinary and Life 
Sciences at the University of Glasgow.  The Research Proposal (Appendix E) for this study 
was approved by Ayrshire and Arran Research and Development Department and ethical 
approval granted by the University of Glasgow College of Medical, Veterinary and Life 
Sciences (Appendix F).  
 
 
 
3. Results 
Six Consultant Neurologists and four Registrar Doctors participated in the research.  The 
participant details are shown in table 1.   
Participant 
Number 
Role Number of years 
practising in current 
role 
Length of 
interview (mins) 
Ss 1 Registrar Doctor 5 34.22 
Ss 2 Registrar Doctor 4 36.36 
Ss 3 Consultant Neurologist 16 32.33 
Ss 4 Consultant Neurologist 15 33.11 
Ss 5 Registrar Doctor 2 44.07 
Ss 6 Registrar Doctor 4 39.54 
Ss 7 Consultant Neurologist 10 44.07 
Ss 8 Consultant Neurologist 3 35.25 
Ss 9 Consultant Neurologist 7 25.20 
Ss 10 Consultant Neurologist 2.5 27.24 (Phone 
interview) 
Table 1: Participant characteristics and interview length 
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Five main themes accounted for the experiences of clinicians when discussing SUDEP: The 
SUDEP Protocol; Diffusion of the FAI; Breaking Good News – ambivalence discussing 
SUDEP; Incorrectly Anticipating Distress; and Pressure hinders effective communication.  
These will be discussed in turn. 
 
3.1 The SUDEP Protocol 
Analysis suggested that the practice of informing patients about SUDEP is uniform with 
only slight variations in practice noted.  Clinicians appear to engage in two types of SUDEP 
conversation; those for patients with newly diagnosed epilepsy (shown diagrammatically in 
Appendix G) and those for chronic, uncontrolled epilepsy patients. 
For chronic uncontrolled epilepsy patients, the SUDEP conversation was invariably used as 
a means of emphasising the risks associated with poor epilepsy control and in an attempt to 
encourage medication adherence: 
‘so as I said the two patient groups - patients who have chronic epilepsy you are 
seeing back and they have poor control and you talk about it.’ (Registrar, Ss2) 
 
Sometimes this conversation would occur with people with long standing epilepsy because 
they had never been made aware of SUDEP: 
‘well there are many patients with long standing epilepsy who may have been 
diagnosed in the days when SUDEP wasn’t discussed but if a long-standing patient 
were to bring up concern about their risks of seizures or potential of harm then we 
would have a discussion about that as well.’ (Consultant, Ss3) 
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Unlike chronic epilepsy patients, clinicians appear to regularly discuss SUDEP with newly 
diagnosed patients: 
‘in the last couple of years or the last few months when I was doing first seizure 
clinics perhaps - almost every new patient, yeah.’ (Registrar, Ss6)  
 
There was one very common exception to this rule - the topic of SUDEP is often not 
mentioned if the patient appears distressed or anxious about the epilepsy diagnosis.  
Clinicians noted that they will make notes to discuss SUDEP at the next appointment or they 
rely on Epilepsy Nurses to discuss SUDEP: 
‘and if they are very anxious during the first consultation I usually do not tell them 
regarding the diagnosis – regarding the SUDEP risk.’ (Consultant, Ss8) 
‘I heavily rely on my follow-up appointment with nurses where they discuss it far 
better than me I think, I believe.’ (Registrar, Ss5) 
 
Clinicians usually raise the issue of SUDEP first.  It was rarer for a patient to initiate a 
conversation about SUDEP following diagnosis: 
Interviewer: ‘has there been cases where they know about SUDEP before you raise 
that?’  
‘No.’ (Consultant, Ss4) 
‘I've certainly seen some patients who have asked about it.  Um, you know I have 
had, you do get informed patients.’ (Registrar, Ss1) 
‘Um, well at new diagnosis, that's uncommon.’ (Consultant, Ss3) 
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Clinicians often raise the topic of SUDEP towards the end of the diagnosis appointment: 
‘…towards the end, generally.  It's usually the last thing we talk about.’ (Consultant, 
Ss4) 
‘Not right at the end. I don’t want it to be the last thing that they’re remembering.  I 
sort of put it in, you know if I’ve got five things to say it as number three or four.’ 
(Consultant, Ss9) 
 
There is often a ‘script’ employed which contains the same information and similar phrasing: 
‘It’s probably a personal script I’m not sure I don’t know if everybody does that, 
yes.’ (Registrar, Ss6) 
‘It’s the same sentence I use most of the time.’ (Consultant, Ss8) 
 
The information tended to include risk factors for SUDEP and it was common to emphasise 
that the risk of SUDEP is low and modifiable.   
‘you can explore that a bit further and say yes there is so much risk but it varies and 
the risk is higher in people who have persistent seizures and it’s important that you 
take your medications and control it and so on.’ (Consultant, Ss7) 
‘[SUDEP is] rare.  Uh, that taking appropriate treatment for epilepsy should help 
avoid it.  And I think those are the main things’ (Registrar, Ss1) 
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Many clinicians noted that they will not actually use the term SUDEP, preferring to state 
there was a risk of harm: 
‘If I tell the patient he might die because of seizures it may increase anxiety but what 
I tell is that - in general these are all the potential consequences one can have with 
epilepsy.’ (Consultant, Ss8) 
‘What I have been doing is discussing that epilepsy can potentially cause serious 
harm but not quite use the ‘death’ word straight away.’ (Consultant, Ss7) 
 
SUDEP conversations, or the lack of them, were commonly documented to the GP. 
‘we will either refer you to the nurse specialist who’ll cover some of it and if not it 
will be covered in the next medical clinic. But I’ll try and document that as much as 
possible that it’s not done.’ (Registrar, Ss6) 
 
Despite the apparent uniformity of practice, clinicians were keen that junior colleagues 
should develop their own style when discussing SUDEP: 
‘I’d probably ask them to review the figures and research it themselves as well.’ 
(Consultant, Ss9) 
 
3.2 Diffusion of the FAI into practice 
Clinicians were aware of the FAI and some explicitly noted their thoughts and feelings 
regarding the ruling having read the inquiry: 
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‘I don't want to point any direction against the sort of judge or the individual people 
or giving evidence but I don't think that was an amazingly useful event that ruling.’ 
(Registrar, Ss1) 
‘it was only after the Sheriff’s ruling a few years ago that it kind of became 
mandatory to bring up SUDEP with patients at the point of diagnosis or soon 
thereafter.’ (Consultant, Ss3) 
‘I think one thing that probably brought SUDEP to the fore was a fatal accident 
inquiry.’ (Registrar, Ss2) 
 
Others expressed a more vague understanding of the FAI: 
‘I think there have been rulings, but I wouldn’t be able to know the specifics of it, to 
say that we should all be informing and making [SUDEP] a priority to discuss.’ 
(Consultant, Ss9) 
 
The suggestion is that the practice of discussing SUDEP has been heavily influenced by the 
FAI ruling. This was in contrast to the impact of guidelines on SUDEP discussions - 
Clinicians were aware that guidelines relating to SUDEP practice existed but universally 
these had not been read. 
The FAI appears to have influenced practice by three mechanisms: initial neurology training, 
teaching days, and discussions with colleagues.  Both Registrars and recent Consultants 
noted that their practice of discussing SUDEP was influenced by their training in neurology: 
‘[my practice] is from my training days itself- I‘ve not read any guidelines but from 
the training days itself.’ (Consultant, Ss8) 
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‘I think there were a few training sessions that I had attended last time when we were 
in ______teaching training day.’ (Registrar, Ss5) 
 
However, the greater influence on practice appeared to be exerted from colleagues, training 
and team discussions: 
‘I’ve gone to outside meetings and … those kind of things. And we’ve had epilepsy 
training days and we have a monthly training day in epilepsy perhaps comes once a 
year or things like that.’ (Consultant, Ss6) 
‘Meetings mostly yes - so reasonably formal departmental meetings.’ (Consultant, 
Ss9) 
‘[I learn it] from peers and epilepsy meetings.’ (Consultant, Ss3) 
 
3.3 Breaking Good News – ambivalence discussing SUDEP 
Individual clinicians expressed both their support and dissatisfaction with the practice of 
discussing SUDEP with newly diagnosed patients.  This ambivalence extended to the 
benefits to patients, the feelings regarding the FAI, and whether it is a Breaking Bad News 
experience or not.  In general clinicians stated that SUDEP was an important topic to discuss 
and patients should be well informed about their condition:  
‘…obviously you want a well-informed patient, and they're autonomous and should 
have as much information as you have.’ (Registrar, Ss2) 
‘I think the practice should be that it is important that the patient has all the 
information of their condition.’ (Consultant, Ss7)  
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Many clinicians viewed SUDEP as a positive topic to discuss as it could increase medication 
adherence and meant that risk issues could be addressed: 
‘I think particularly if someone is swithering about compliance for medication – then 
I think a discussion of SUDEP can make them more adherent to the 
recommendations.’ (Consultant, Ss10) 
‘I want to frame it and structure it in a way that they think that compliance, lifestyle 
modification - if I do these two things well from my end then, actually, I am working 
towards less risk of coming to harm with these seizures. I want to bring a positive 
approach towards it.’ (Registrar, Ss5) 
 
An alternative feeling was also commonly expressed: 
‘I think there is an argument for should you discuss it should you not and clearly the 
court has made a decision and that's…but I think there is still an argument as to 
whether patients should be burdened by this worry’ (Consultant, Ss4). 
‘I think that the guideline that you tell everyone um leaves slightly at the discretion 
of the clinician.  And it’s a bit like any other guideline it’s a one size does not always 
fit all.  So I think it might be clinically appropriate to leave that to a subsequent 
consultation to discuss.  Particularly if someone is upset having received a diagnosis 
of epilepsy.’  (Consultant, Ss10) 
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It was this mixture of positive factors, together with the potential anxiety caused to patients, 
and the perception that the FAI recommendations are mandatory that has created the 
ambivalence.    
Clinicians were unaware of the impact of discussing SUDEP with patients on their behaviour 
however they hoped that it might influence them positively:   
‘they probably contribute to good compliance and you know, possibly, they lead to 
more regular lifestyles and avoidance of binge drinking and other drugs and, I don't, 
I have no evidence to prove it but that’s the hope.’ (Consultant, Ss3) 
‘would hope it would make a difference to them is for them to take control of their 
condition and try and you know as I say get regular sleep, get the regular meals, 
avoid alcohol in excess, avoid drugs and take their medication that's what I'm hoping 
for.’ (Registrar, Ss2)   
 
Clinicians were divided as to whether they considered discussing SUDEP a BBN experience: 
‘no I don't think it's breaking bad news because it's not happened to them it’s just, 
you're just telling them about a potential risk and you've already gone through a lot 
of potential risks about epilepsy by that stage as well.’ (Registrar, Ss2) 
‘sort of, yeah, it's an educational thing.  Sort of breaking bad news.’ (Registrar, Ss1) 
‘I’d say it’s breaking good news you know there is this risk but it’s usually very, very 
low.’ (Consultant, Ss9) 
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Clinicians noted that they had not needed or considered personal support for any 
conversation about SUDEP with patients.  Support could come in the form of discussions 
with colleagues or supervisors however it seemed rare for clinicians to do this. 
 
3.4 Falsely Anticipating Distress 
Clinicians stated that they were likely to cause anxiety by discussing SUDEP.  There were 
suggestions that clinicians were unduly worried about what the reaction might be from their 
patients: 
‘but I think it’s, if it was said to me I think it would be something that would sit you 
know if I had epilepsy and somebody told me 'you could go to sleep and have a 
seizure and not wake up' or 'you could have seizure and die from that' I suppose that 
would worry me, a lot.’ (Consultant, Ss4) 
‘and then very softly say the word death - because it’s frightening … (later on) I think 
that is more fear in the medics approaching this topic rather than in patients 
discussing this.’ (Registrar, Ss5) 
‘because if they've not had a seizure for a while and they're on medication then why 
bring up something that could cause them distress?’ (Consultant, Ss3) 
 
Interestingly, there was only one account of a patient reacting badly to the SUDEP 
discussion.  No other clinicians had encountered a bad reaction from any patient when 
discussing SUDEP.  Instead, the general picture is that patients react calmly perhaps only 
occasionally expressing surprise: 
59 
 
‘um so maybe slight surprise - not people getting upset though I don't think in my 
experience.’ (Registrar, Ss2) 
‘I’ve not seen any patient giving any anxious reactions so far.’ (Consultant, Ss8) 
 
There was some surprise expressed at the fact that patients react so calmly to SUDEP 
information and some suggestions as to why this is the case.  Clinicians felt that the epilepsy 
diagnosis, or the impact of the condition on their lifestyle, was more distressing than 
information about SUDEP: 
‘I think the majority, again, 4 in 5 will respond, pretty surprisingly, without anything. 
They will just take that as factual information.’ (Registrar, Ss6) 
‘some people are more concerned about their employment, lack of driving so they 
kind of focus on that.’ (Registrar, ss2) 
‘often the implications of the seizure on their driving activity and other things is of 
greater concern to them than what is a relatively small risk [of SUDEP].’ 
(Consultant, Ss10) 
‘rather than [SUDEP] because [lifestyle factors] have the impact you know, do they 
manage their sleep better, do they take alcohol, are they using recreational drugs on 
top of that? Are they looking after themselves better? So that’s really important.’ 
(Consultant, Ss7) 
 
Clinicians suggested that the cautious approach clinicians take may result in the settled 
manner patients receive the news.  The suggestion was that their way of discussing SUDEP 
reduced patients’ anxieties: 
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‘Uh, I tell in a very smooth manner so that it does not hurt or does not make them 
very anxious.’ (Consultant, Ss8) 
‘I think to be honest I have never seen it too positive or too negative. There is one 
standard conversation. And I don’t know if maybe I am getting it too easy (laughing) 
or, if it’s just me.’ (Registrar, Ss5) 
 
In general clinicians do not find discussing SUDEP with patients an anxiety provoking 
experience: 
‘Um…I feel happy talking about it, I feel comfortable talking about it.’ (Registrar, 
Ss2) 
 
There were suggestions that the initial change of practice brought about as a result of the 
FAI had been anxiety provoking: 
‘So again when the practice was slowly changing and I thought I should introduce 
this with every diagnosis. I think initially it was difficult I always felt a little anxious 
on how to introduce the subject.’ (Registrar, Ss6)  
 
It appears that some clinicians were initially anxious about discussing SUDEP however 
patients’ reactions alleviated this anxiety. 
‘Initially I used to be hesitant but nowadays because it’s become routine and after 
observing the reaction from the patient because it’s not an anxiety reaction it is a – 
they feel it is something like expected.’ (Consultant, Ss8) 
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3.5 Pressure hinders effective communication 
Despite reporting that SUDEP is not a distressing experience for them, clinicians did not 
report universal satisfaction with the requirement to discuss it.  It appears that pressure 
affects clinicians’ ability to communicate SUDEP information in a number of ways.  In a 
practical sense, many clinicians note that the main difficulty they had with SUDEP 
conversations was the limited time they had to discuss the information in addition to 
diagnosing epilepsy: 
‘so there's lots of things we have to talk about, or we feel pressure to talk about.  We 
have to talk about lots of different bits that's just one of the other things we have to 
talk about.’ (Registrar, Ss2) 
‘there is a lot to cover in a 30 minute consultation.  You take the history from the 
patient, sometimes from a witness of a possible event when they’ve lost 
consciousness.  You’re asking them about their past medical history, you’re clinically 
examining them, you are going over investigations they may have had, if they’ve had 
imaging, you then sort of discuss the diagnosis you talk about drugs – you don’t have, 
it’s something that is kind of shoehorned in – you don’t have, it’s one of a list of 
things you need to do.’ (Consultant, Ss10) 
 
As a result of the limited time, clinicians wondered if this led to patients being ‘overloaded’ 
with information.  Clinicians wondered if this affected patients’ ability to understand their 
discussions about SUDEP.  This may also be the reason that patients accept the diagnosis so 
calmly: 
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‘so by the time you come to it the patient already has a lot to absorb. And that’s why 
I think they’re already in their minds you know, trying to grasp as much information 
as they can, so they don’t immediately show a response that I have seen.’ (Registrar, 
Ss5) 
‘I think the new patients are sort of slightly numbed by the time you start to talk about 
it or are slightly overwhelmed already so they are less likely to engage and ask lots 
of questions about it I think, in my experience.’ (Registrar, Ss2) 
 
There was also a suggestion that the pressure clinicians are under in the initial session to 
correctly diagnose epilepsy may mean that SUDEP is not given the appropriate emphasis: 
‘So you’ve got a very limited time to try and sort of, we say getting the diagnosis 
right and conveying that to the patient is the primary aim.’ (Consultant, Ss7) 
 
In a broader sense clinicians noted their feelings regarding the pressure to discuss SUDEP 
as a result of the FAI.  Clinicians acknowledged the pressure they felt and questioned if the 
legal system should recommend medical advice to patients: 
‘and from my perspective too I also need to play safe from the medical legal point of 
view.’ (Consultant, Ss8) 
‘but whether one feels [discussing SUDEP] is appropriate or not, the fact is if you 
choose not to do it you're laying yourself open to risk - medical legal risk.’ 
(Consultant, Ss3) 
‘I think it's probably a bit unfortunate that the way we practice medicine, and this as 
an example, is not - the decision does not come from the doctors.’ (Consultant, Ss4) 
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 ‘now I think the drive is very much for us to talk about it, bring it up, and also bring 
it up early talk about it on day 1.’ (Registrar, Ss2)    
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4. Discussion 
This research found five main themes that accounted for clinicians’ experiences when 
discussing SUDEP.  Clinicians appear to employ a standardised way of discussing SUDEP 
(‘the SUDEP protocol’); the recommendations of the FAI have diffused into their practice 
through meetings and training; clinicians feel that discussing SUDEP has both negative and 
positive aspects to it; they report that patients are not distressed by SUDEP information, 
although they appear to be concerned that it will be distressing for them; and there is concern 
that the pressure to discuss SUDEP information soon after diagnosis may hinder 
communication.  The results of this study would corroborate recent research which suggests 
that clinicians in Scotland are regularly discussing SUDEP with newly diagnosed epilepsy 
patients [13, 24].  The participants in the current study also suggested that SUDEP was not 
routinely discussed with historically diagnosed epilepsy patients.  Both of these findings 
would not be surprising given that the epilepsy guidelines and the FAI refer to newly 
diagnosed patients only and have not explicitly stated that the risk of SUDEP should be 
raised with chronic patients [27]. 
It was clear that the FAI has had an impact on clinicians practice in Scotland.  Even those 
who were unaware of the specific details of the FAI had their practice impacted.  The FAI 
has created a pressure to discuss SUDEP that is exerted through meetings and discussions 
amongst Neurologists.  Interestingly, this did not seem to be the case for the medical 
guidelines as clinicians appeared unaware of their content or implications.  Systematic 
reviews suggest that it is difficult to predict if medical guidelines will have an impact on 
practice [33], however, they are more likely to be successful when introduced alongside 
rigorous evaluations of their impact [34]. Given that medical guidelines are almost 
ubiquitous and FAIs into medical practice somewhat rarer, it may be harder to generalise 
their impact on medical practice. The current study would suggest that compared to medical 
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guidelines, an FAI has a much greater ability to influence medical practice.  This may have 
been because some clinicians interviewed felt that they were at medical-legal risk if they did 
not discuss SUDEP. 
The influence of the FAI recommendation appears to have resulted in a ‘protocol’ for 
discussing SUDEP.  Clinicians noted that many of the epilepsy diagnosis sessions can take 
a similar format and SUDEP has clearly been added to the list of necessary topics to discuss.  
Moreover, there appears to be a standardised way of discussing SUDEP towards the end of 
diagnosis sessions and a similar approach noted in terms of discussing a ‘risk of harm’, rather 
than death, and noting measures that patients can take to reduce risk.  This SUDEP protocol 
for chronic epilepsy patients is not as detailed as the protocol for initial diagnosis, however, 
clinicians appeared to be more effusive towards the benefits of such a discussion.  
While the FAI has affected practice, it has also been met with some resistance from 
clinicians.  Miller et al. [19] had found that clinicians in their study suggested it was ‘morally 
wrong’ to give information about SUDEP because it was poorly understood, and difficult to 
prevent.  Clinicians in the current study were more likely to suggest that the information 
could have the potential to make a patient anxious or distressed – and this was an unnecessary 
reaction given the risk of SUDEP occurring.  Additionally, the resistance to discuss SUDEP 
arose because the communicated message was deemed to be less effective following the 
emotional impact of the epilepsy diagnosis.  Psychological research would broadly confirm 
the clinicians’ sentiments.  Anxiety and memory recall for medical information is proposed 
to be negatively and inversely related (too low, or high a level of anxiety will impair recall 
[35]).  Disclosure of the epilepsy diagnosis may well result in attentional narrowing [36] 
resulting in less attentional resources available to process and recall SUDEP information 
[37]. 
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The FAI has created a time pressure for clinicians to discuss SUDEP promptly upon 
diagnosis and this, again, creates a concern that the information about SUDEP will not be 
conveyed sympathetically or that patients will not be able to explore or understand the 
information in sufficient detail.  There is, in effect, a potential emotional and informational 
cost when discussing SUDEP at diagnosis.  The patients in the Tonberg et al. [24] study also 
suggested that SUDEP information should be given in the session following diagnosis, given 
the emotional impact of receiving an epilepsy diagnosis. Again, this would offer further 
support, from the patient’s perspective, that memory recall is adversely affected in high 
levels of distress and anxiety [35]. 
Friedman et al. [18] had found that many clinicians had feared an anxious response in their 
patients when discussing SUDEP.  This feeling was shared by the clinicians in the current 
study. However, a number of additional statements can be made about this finding.  Firstly, 
although clinicians in the current study were mindful of not creating an anxious response in 
patients, it was clear that they were not anxious about having the discussion themselves.  
Although some clinicians reported an initial anxiety, most now reported to feel comfortable 
having the conversation and conveying SUDEP information to patients.  This is in 
concordance with other research which suggests that despite the difficulties involved, 
doctors in general feel comfortable with BBN experiences [20].  Secondly, despite 
anticipating an anxious response from patients, there were almost no accounts of this 
occurring.  This finding is corroborated by Harden et al. [13] and Tonberg et al. [24] as 
patients in these studies reported that SUDEP information created only short-lived anxiety.  
There may be a suggestion that the cautious approach employed by clinicians, and their 
anticipation of anxiety, may create the circumstances and atmosphere which results in the 
calm response from patients.  Patients’ remember less information when their clinician 
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appears anxious suggesting that a calm demeanor may facilitate memory recall and lessen 
emotional impact of a diagnosis [38]. 
Similar to findings in America, clinicians felt that patients had a right to know about the risk 
of SUDEP [19].  Clinicians also felt that the conversations about SUDEP might possibly 
influence adherence to medication.  Medication adherence is a multi-factorial process with 
numerous studies investigating the impact of providing information, self-monitoring, 
psychological therapy and many more interventions [39].  Evidence would suggest that a 
conversation with a clinician would, at best, have only a modest influence on rates of 
medication adherence [40].  Moreover, research has suggested that providing risk 
information at one point only is not effective in increasing medication adherence in patients 
with Coronary Heart Disease [41].  Interestingly, research suggests that patients themselves 
do not feel information about SUDEP impacts their health behaviours however they feel they 
have a right to all the information about their condition [13, 24].   
The Necessity-Concerns Framework (NCF [42]) suggests that for medication adherence to 
be successful a patient needs to understand the necessity to take their medication and their 
concerns of possible medication side effects also needs to be addressed.  The clinicians in 
the current study were very clear with regards to the necessity of medication adherence with 
regards to SUDEP prevention – it may be that exploring the potential side effects of epilepsy 
medication could also increase adherence rates.   
 
4.1 Limitations 
It should be noted that the participants in this study were volunteers and likely to be 
interested or engaged in the practice surrounding SUDEP.  This could have resulted in a 
more extreme view being expressed either in favour of or against the current practice.  
68 
 
Moreover, clinicians in this study expressed concern that they would be at legal risk if they 
did not discuss SUDEP with newly diagnosed patients.  It would be understandable if those 
clinicians who do not practice in the legally suggested way may have avoided participating 
in the current study.  
Clinicians did raise additional themes about the practice of discussing SUDEP when asked 
if they had additional thoughts at the end of the interview.  These themes were explored in 
subsequent interviews however one theme was raised that patients with chronic epilepsy 
may become more anxious as a result of learning about SUDEP, especially if their epilepsy 
was not controlled at present.  Due to this theme being expressed by a participant late in the 
recruitment process, this was not able to be fully verified and explored with other data 
sources.  This may have proved interesting to analyse in further detail.   
In a similar regard, clinicians expressed that support was available to them however this 
appeared to be rarely used.   Exploring how clinicians utilise and request support from 
colleagues may be best met with an alternative methodology.  Notably, it was felt that 
clinicians often appeared hesitant and in some cases avoidant when asked about how they 
utilise or require support.  An Interpretive Phenomological Analysis may be more suited to 
explore this hesitancy and to analyse how the participant is making sense of this phenomenon 
[43].   
 
4.2 Implications for Research and Practice 
Concerns about the impact of SUDEP information on patients remain. Clinicians in the 
current study expressed interest in establishing whether their conversations about SUDEP 
made a difference to patients’ behaviours.  Although qualitative research has suggested that 
patients profess this is not the case [13, 24], and previous research has suggested that a 
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clinical conversation in isolation is unlikely to alter an individual’s health behaviours [40], 
it may be useful to quantifiably measure the behaviour change that results from SUDEP 
conversations.    
This research highlighted the impact of guidelines on medical practice.  While clinicians 
were aware that guidelines exist, many were unaware of the contents.  It appears that, in this 
case, FAI recommendations have had a much greater impact on practice than the guidelines 
suggested by the medical profession itself.    
In terms of guideline development, this research has highlighted the additional pressure and 
concerns that can arise as a result of a ‘blanket’ approach to practice.  This research has 
strengthened the findings that clinicians value a sense of clinical autonomy [19].  With 
regards to the practice of discussing SUDEP, removal of this autonomy resulted in clinicians 
becoming concerned about the quality and emotional impact of the conversation.    
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Appendix 2.  Search Terms for Systematic Review 
MEDLINE and EMBASE: 
 
Epilep*.mp. OR seizure*.mp. OR tonic-clonic.mp. OR (tonic adj clonic).mp. OR exp 
epilepsy/ OR exp seizure 
AND 
diagnos*.mp. OR (patient* adj2 experience*).mp. OR (patient* adj2 perspective*).mp. OR 
(patient* adj2 reaction*).mp. OR personal experience.mp. 
AND 
qualitative research.mp. OR qualitative analysis.mp OR exp qualitative research/ OR 
content analysis.mp. OR thematic analysis.mp. OR grounded theory.mp. OR Interpretative 
Phenomenological Analysis.mp.  
 
PsychINFO: 
 
epilep* OR seizure* OR "tonic clonic" 
AND 
diagnos* OR patient* N2 experience* OR patient* N2 perspective* OR patient* N2 
reaction* OR personal experience 
AND 
qualitative research OR qualitative analysis OR content analysis OR Interpretative 
Phenomenological Analysis OR thematic analysis OR grounded theory 
 
Web of Science 
(epilep* OR seizure* OR "tonic clonic")  
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AND  
TOPIC: (diagnos* OR patient$ NEAR/2 experience$ OR patient$ NEAR/2 perspective$ 
OR patient$ NEAR/2 reaction$ OR personal experience)  
AND 
 TOPIC: (qualitative research OR qualitative analysis OR content analysis OR 
Interpretative Phenomenological Analysis OR thematic analysis OR grounded theory) 
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Appendix 3: Quality Assessment of studies using Walsh and Downe [16] checklist 
Study  Clear 
rationale 
Contextualised 
by 
literature 
Method 
appropr
iate 
Data 
collection 
strategy 
appropria
te 
Sample/
sampling 
appropri
ate 
Analytic 
approach 
appropri
ate 
Context 
described 
Clear 
audit 
trail 
Data in 
support 
of 
interpret
ation 
Researcher 
reflexivity 
Sensitive 
to ethics 
Relevance & 
transferability 
 [23] Y Y Y  Y  Y Y  Y Y Y  N (Y) Y (N) Y  
[10] Y Y Y Y  N  Y    Y Y Y N  Y Y 
[21] β Y Y Y Y Y Y Y Y Y Y Y Y 
[4] Y Y Y N Y N Y Y Y Y N Y 
[7] * Y Y Y Y Y Y Y Y Y Y Y Y 
[20]* Y Y Y Y Y N (Y) Y Y N (Y) N Y (N) Y 
[18] Y N Y Y Y Y N Y N N Y Y 
[24] Y Y Y Y Y Y Y Y Y N Y (N) Y 
[5]  Y Y Y Y Y Y Y Y Y Y Y Y 
[22] Y N Y Y Y N N Y Y N N Y 
[9] Y Y Y Y Y Y Y Y Y Y Y Y 
[19] Y Y N Y N Y N N Y N N Y 
[6]β Y Y Y Y Y Y Y Y Y Y Y Y 
*Same sample studied, different focus of study 
β Same sample studied, same focus of study,  alternative conclusions and themes considered.  Differing assessment by the co-rater is 
indicated in brackets.  These were discussed and consensus achieved (shown underlined)  
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Appendix 4: Studies assessed using Dixon-Woods et al., [17] Fatally Flawed Criteria 
 Baca 
[23] 
Buelow 
[10] 
McNelis 
[4] 
Miller 
2014a 
[20] 
Nair 
2013 
[18] 
Nair 
2016 
[24] 
Risdale 
[22] 
Thomas 
[19] 
Are the aims and 
objectives of the 
paper clearly 
stated? 
Y Y Y Y Y Y Y Y 
Is the research 
design clearly 
specified and 
appropriate for the 
aims and 
objectives of the 
research? 
Y Y Y Y Y Y Y Y 
Do the researchers 
provide a clear 
account of the 
process by which 
their findings were 
produced? 
Y Y Y Y Y Y Y N 
Do the researchers 
display enough 
data to support 
their 
interpretations 
and conclusions? 
Y Y Y Y N Y Y N 
Is the method of 
analysis 
appropriate and 
adequately 
explicated? 
Y Y Y Y N Y Y N 
 
Critique of the Nair, Jack, Meaney and Ronen [18] and the Thomas et al. [19] papers. 
Nair, Jack, Meaney and Ronen [18] referenced only two papers that investigated families 
affected by SUDEP and one survey of patients’ views to contextualise their research.  
Thomas et al. [19] employed a thematic analysis to determine themes in their participants’ 
interviews followed by an interpretive phenomological analysis to develop themes.  They 
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did not provide an explanation of why this method was used.  Thomas et al. [19] also did not 
justify the sample size (having approached 25 participants, 14 were interviewed) and it is 
unclear when the transcription and interviewing phase was conducted.  It was felt that both 
papers did not give adequate details of the participants in terms of providing details about 
the social and interpersonal contexts of research participants. The decision trail of Thomas 
et al’s. [19] paper was not clear to follow. 
Nair et al. [18] did not use any quotes from participants so it was unclear how the data had 
been used to support their findings.  Thomas et al. [19] could also have considered support 
for participants who had been distressed discussing their experiences. 
Both papers did not meet fatally flawed criteria based on Dixon-Woods et al. [17] criteria 
and were excluded on this basis. 
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Appendix 5: Illustrative example of third order themes relating to Article themes for Baca et al. [23] 
Study (year) Method of 
analysis 
Participants Article themes 
relating to 
diagnosis 
Detail of themes Discussion 
based themes 
3rd Order Themes 
 
Baca et al (2015) 
[23] 
Thematic 
analysis 
37 individual 
interviews with 
parents of children 
with epilepsy who 
had undergone 
resective epilepsy 
surgery 
Theme 1: 
Recognition 
‘something is 
wrong’. 
 
 
 
 
 
 
 
Onset of seizures is 
frightening 
‘parents describe a feeling 
of ‘desperation to get a 
diagnosis’ p825. 
 
Parents are unfamiliar with 
what epilepsy is 
 
Having no idea what it is 
but needing medical 
treatment. 
 
 
 
 
 
 
Intervention to 
help families 
‘learn the 
language’ of 
epilepsy 
Initial onset - frightening 
 
 
 
 
 
Initial onset - Parents don’t 
recognise initial seizures  
 
 
 
 
Theme 2: 
Searching and 
finding: ‘a 
journey 
around the 
world and 
very 
circuitous’ 
 
 
Overwhelming amount of 
information ‘avalanche of 
information coming at us’ 
p825 
 
Several parents reported 
feeling doubted by their 
doctor 
 
Personal and family stress 
experienced throughout 
the journey – becoming a 
caretaker or advocate for 
their child 
 
  
Time to process – too much 
information during the diagnosis 
 
 
 
Relationship with Healthcare staff-  
Feel doubted by doctors 
 
 
Role change - Parents become an 
advocate for their child 
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Appendix A: Interview Schedule 
 
 
These questions were designed to facilitate the conversation and often evolved to 
focus more on specific areas depending on the issues and themes encountered in 
initial interviews. 
 
Most questions were expanded with follow up prompts.  Examples of prompts are 
given in bullet points below.   
 
Demographics: 
 
Can you describe your role to me? 
 
How long have you been practicing in your current role? 
 
In a typical week or month, how many people would you discuss SUDEP with? 
 
Knowledge 
 
What can you tell me about SUDEP? 
 
What factors influence the risk? 
 Prompts: What controllable risks exist? What uncontrollable risks exist? 
 
Are there any guidelines that inform you about SUDEP and what to discuss with 
patients? 
 Prompts: What do SIGN/NICE guidelines say in the subject? 
 
Are there any local NHS policies that affect your practice with regards to SUDEP 
discussions? 
 Prompts: Can you tell me about these? 
 
Typically, what do patients know about SUDEP before you speak to them? 
 Prompt: What sources of information have you used? 
 
Practice/Intention 
 
“I am now interested in finding about your typical practice or how you would normally 
wish to discuss SUDEP with a patient” 
 
When would you typically first discuss SUDEP with a patient? 
 
What influences the timing of when you discuss SUDEP? 
 Prompt: are there times or situations when you won’t discuss SUDEP? 
 
How is the topic of SUDEP usually first raised? 
 
How do you feel when you know you are about to discuss SUDEP with a patient for 
the first time? 
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What key messages do you hope that patients take away with them? 
 Prompt: Is there anything you do to help get these messages across to 
patients?  
 
Experience 
 
“I am interested in hearing about some specific experiences you have had 
discussing SUDEP with patients.” 
 
Can you tell me about the last time you discussed SUDEP with a patient or carer? 
 Prompts: Who initiated this discussion? 
 What did you tell the patient/carer about SUDEP? 
 What did the patient/carer ask about? What information did they already 
have? Where had they got this information from? 
 How did the patient/carer seem to react/cope with the discussion? 
 How did you feel about this discussion? 
 What did you do to cope with this discussion?  
 Looking back, is there anything you think you could have done/said 
differently? 
 Would you say this was typical as to how SUDEP is discussed?  
 
Can you tell me about a SUDEP discussion that particularly stands out as a difficult 
discussion? 
o Prompts: What was it that was difficult about this discussion? 
o Who initiated this discussion? 
o What did you tell the patient/carer about SUDEP? 
o What did the patient/carer ask about? What information did they already 
have? Where had they got this information from? 
o How did the patient/carer seem to react/cope with the discussion? 
o How did you feel about this discussion? 
o What did you do to cope with this discussion?  
o Looking back, is there anything you think you could have done/said 
differently? 
o Would you say this was typical as to how SUDEP is discussed?  
 
 
Can you tell me about a SUDEP discussion that particularly stands out as a good or 
positive discussion? 
o Prompts: What was it that was positive about this discussion? 
o Who initiated this discussion? 
o What did you tell the patient/carer about SUDEP? 
o What did the patient/carer ask about? What information did they already 
have? Where had they got this information from? 
o How did the patient/carer seem to react/cope with the discussion? 
o How did you feel about this discussion? 
o What did you do to cope with this discussion?  
o Looking back, is there anything you think you could have done/said 
differently? 
o Would you say this was typical as to how SUDEP is discussed?  
 
Reflection/thoughts on the future 
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“I would like to hear some of your reflections on your experiences and any thoughts 
about what could support your practice.” 
 
Looking back on your experiences, what could make SUDEP discussions easier for 
you or the patient? 
 In particular, are there any resources or training courses that could help? 
 
Has your way of discussing SUDEP changed over time? 
 
How do your discussions about SUDEP compare with other times you have had to 
discuss other ‘bad news’ with a patient? 
 
If you had a difficult experience discussing SUDEP what would you do? 
Prompts: Is there anyone you would go to for support? 
 Is there anything else you would do following a difficult experience? 
 
How do your SUDEP discussions make a difference to patients’ behaviour? 
 
What advice would you give to a junior colleague regarding how to have SUDEP 
conversations and what to say? 
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Appendix B: Participant Information Sheet 
 
 
 
Participant Information Sheet  
 
Clinician experiences of educating patients about SUDEP: How to talk about death when 
required to do so? 
Researcher: Tom Nisbet, Trainee Clinical Psychologist, t.nisbet.1@research.gla.ac.uk   
Academic supervisor: Dr Sue Turnbull, University of Glasgow, sue.turnbull@gla.ac.uk,  
Field supervisors: Dr Sharon Mulhearn, Consultant Clinical Lead Neuropsychology, NHS Ayrshire 
and Arran; Dr Saif Ravzi, Consultant Neurologist, NHS GG+C 
Research undertaken for a Doctorate in Clinical Psychology, Mental Health and Wellbeing, 
Institute of Health and Wellbeing, University of Glasgow. 
 
You are being invited to take part in a research study. Before you decide it is important for you to 
understand why the research is being done and what it will involve. Please take time to read the 
following information carefully and discuss it with others if you wish. Please ask me if there is 
anything that is not clear or if you would like more information. Take time to decide whether or not 
you wish to take part. Thank you for reading this 
 
1. What is the purpose of the study? 
The study will aim to understand and explain the experience of Neurologists or Registrar Doctors 
who talk to their patients about Sudden Unexplained Death in Epilepsy (SUDEP). This will involve 
a one-to-one interview between the researcher and a Neurologist/Registrar Doctor.  An interview 
should last between 30-60 minutes and the data collection will aim to be complete by April 2016.  
The interviews will be analysed qualitatively using a thematic analysis approach to look for themes 
which explain the experiences of clinicians.   
 
2. Why have I been chosen? 
You have been chosen because you are a Neurologist that has worked with people diagnosed with 
Epilepsy in Scotland for at least one year or because you are a Registrar Doctor who has worked in 
a Neurology placement and the Consultant has passed your details onto me.  The research will 
involve between 6 – 12 Neurologists. 
 
3. Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part, you will be asked 
to sign a consent form. If you decide to take part, you are still free to withdraw at any time and 
without giving a reason.’ 
 
4. What will happen to me if I take part? 
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If you chose to take part the researcher will contact you on the contact details you have provided 
(please feel free to contact the researcher using the details above if you haven’t signed up to the 
project and wish to partake).  The researcher will organise a time with you that is suitable to see 
you at your place of work and conduct a 30-60 minute interview.  The interview will be about your 
experiences of discussing SUDEP with your patients.  The interview will be taped on a digital 
voice recorder and transcribed onto an encrypted university laptop.   
 
5. What are the possible disadvantages and risks of taking part? 
There may be an inconvenience to participation as interviews are expected to last up to 60 minutes.  
To reduce this researcher will travel to the participants’ place of work and offer full flexibility in 
terms of available times for the interview. 
 
As the overall numbers of clinicians working in this area is small there is a risk that individuals 
could be recognized. To address this, in addition to removing all names transcripts of the 
interviews will be redacted for any location information which may identify participants.  
 
There may be a risk that the content of the discussions is upsetting for you (e.g. recalling difficult 
conversations or clinical decisions).   
 
 
6. What are the possible benefits of taking part? 
 
You will receive no direct benefit from taking part in this study. The information that is collected 
during this study aims to explore and identify support mechanisms for this area of practice. 
Exploring this may help you to recognise these support mechanisms in your own practice. 
Disseminating the findings may help to develop good practice in this area.  
 
7. Will my taking part in this study be kept confidential? 
All information, which is collected about you during the course of the research, will be kept strictly 
confidential. You will be identified by a pseudonym and any information about you will have your 
name and location details removed so that you cannot be recognised from it.  Additionally, because 
the sample size is small, transcripts of the interviews will be redacted for any location information 
which may identify participants.   
Data will be stored at the University of Glasgow for ten years after the research is completed in line 
with the University’s Code of Good Practice in Research. 
Data will be anonymised and stored in line with the University of Glasgow’s Code of Good 
Practice in Research (http://www.gla.ac.uk/media/media_227599_en.pdf). Anonymity will be 
preserved by recruiting from across Scotland and redacting location and other identifying 
information from transcripts. An encrypted university laptop will be used to store the transcribed 
recording.  The transcription will be satisfactorily checked for accuracy against the recording, and 
then the recording will be erased. 
 
8. What will happen to the results of the research study? 
The results of the study will be written up to form part of a completed Clinical Psychology 
Doctoral dissertation.  Additionally, the research will be written up with the goal of being 
published in a medical journal.   
 
9. Who is organising and funding the research? 
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The research forms part of the Doctoral award conferred by the University of Glasgow funded by 
NHS Education for Scotland.   
 
10. Who has reviewed the study? 
The research has been reviewed and approved by the College of MCLS Ethics committee at the 
University of Glasgow.  
 
11. Contact for Further Information  
Tom Nisbet, Trainee Clinical Psychologist, t.nisbet.1@research.gla.ac.uk.   
Academic supervisor: Dr Sue Turnbull, University of Glasgow, sue.turnbull@gla.ac.uk, 0141 
2113937 
 
Thank you for taking part in this study 
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Appendix C: Sample of transcript coding (5th Participant) 
 
 Code Theme 
First of all I try and enquire about your 
understanding of, you know, what epilepsy is and 
what risk you have.  Normally I lead it with an 
open question - so what do you know about 
epilepsy?  You know, what is the condition? And 
normally this leads me to the conversation. 
Gain understanding of 
epilepsy from patient 
 
Use open questions 
 
 
I normally say that you know there is a risk 
associated with epilepsy – that people, we know 
people can come to harm with epilepsy - 
especially if it is not treated or medication is 
missed. This is a small risk. But it is there.  That 
is why we have to mention it. Epilepsy is 
treatable in the majority of cases and if it is well-
controlled the risk goes down. That’s why it’s 
even more important to know there is a risk and 
that the risk can be reduced further. That’s why I 
don’t want to try and terrify individuals by saying 
‘oh my god – it’s death’ if, you know, the minute 
that word is mentioned people don’t engage and, 
you know, they don’t register much after that. So 
I bring it as a positive thing and say “there is a 
risk but it is controllable and more defiable if 
you’re on treatment and if you are compliant with 
your medication in the majority of the cases that 
risk can be reduced.  But it's worthwhile knowing 
so that you can maybe change some lifestyle if it 
is risky and may be involved lots of alcohol, late 
nights you know, awakenings or lack of sleep and 
travelling too much and all that so… I kind of 
don’t directly say ‘SUDEP - this is the risk factor, 
there are people who die with it’ I introduce it as 
one of the factors that need to be aware of and 
how that can be improved to bring a positive - 
and they register it more and you know, they are 
less terrified and I think they say “oh well it’s 
there but we can do something about it” 
Risk with sudep but 
small 
 
Untreated increases risk 
but its small 
 
 
 
Don’t want to terrify 
individuals 
 
‘death’ and they don’t 
engage 
 
Compliance means risk 
is reduced 
 
Lifestyle factors affect 
risk 
 
 
 
Introduce SUDEP as a 
positive 
 
 
 
Sudep for adherence 
 
 
Emphasises rarity 
 
 
 
 
Anticipating anxiety 
 
 
Difficulty with term 
‘death’ 
 
SUDEP for adherence 
 
 
 
 
 
 
 
SUDEP for adherence 
So it’s almost like a way of encouraging them 
to get their epilepsy under control? 
  
Yeah controlled SUDEP for control  
You mentioned that you know as soon as the 
word ‘death’ is mentioned it can be a kind of, 
you know, not wanting to terrify people  - is 
that a kind of typical reaction you’ve seen 
before? 
  
I think have not seen it because I have seen that 
people when you talking to them – the problem is 
at the first seizure clinic there is little time and so 
Not seen terrified 
patients before 
 
Patients not upset by 
SUDEP info 
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much to discuss. The driving, their lifestyle, 
diagnosis, prognosis, certainty of diagnosis and 
everyone has their own questions as to what is 
my next generation risk and all that - so by the 
time you come to it the patient already has a lot to 
absorb. And that’s why I think they’re already in 
their minds you know, trying to grasp as much 
information as they can, so they don’t 
immediately show a response that I have seen.  
They kind of go like blank face and trying to get 
what you are saying. So when they come back for 
the second or third appointment that’s when they 
open up and say “you mentioned about that and 
you know what’s my risk? And I have been 
thinking about it…” so I do you see that they kind 
of cling onto that information but not 
immediately react. 
Time factor to discuss 
many things 
 
A lot to absorb for 
patients 
 
 
 
Patients talk more about 
sudep in second or third 
apt 
 
 
Retain information 
about SUDEP in first 
apt? 
Time pressure 
 
 
Information overload 
 
 
 
 
 
Information overload 
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Appendix D: List of Overall Themes 
 
The SUDEP protocol  
SUDEP for initial SUDEP for chronic – ss3 wait for chronic to raise it? 
Won’t discuss if chance is remote ss9 
More SUDEP conversations now than in the past (even for ST3 ss6) ss9 
Difficulty with the term – death, ss7 ss8 cf ss8 write down the term ss9 
sudep raised by clinician (Rare for patients to be aware of SUDEP cf ss8) ss8 
Discuss at diagnosis –cf ss4 cf ss7 staggered approach to SUDEP discussion 
Won’t discuss if patient is distressed at diagnosis 
Don’t discuss – patients reaction 
Consider written information ss9 
Discuss SUDEP at end of session ss8 cf ss9 in the middle 
Use of script ss8 
Rapport important ss6 ss7 
Will document sudep conversation ss8 
(Risks for SUDEP - Don’t know what causes SUDEP, Nocturnal risk factor, Lifestyle 
factors) 
Epilepsy nurses can discuss sudep in more detail – better, soon ss7 ss8 ss9 ss10 
 
Diffusion of the FAI into practice 
Unaware of guidelines cf ss4 (encourage junior colleagues to read guidelines) 
Unaware of policy 
Desire for clinical judgement (moral autonomy – Miller paper) 
Continuing debate regarding SUDEP ss3 ss4 
Learning Practice 
knowledge of SUDEP through teaching (Reg) (Cons ss8) 
knowledge of sudep through colleagues 
SUDEP conversations shaped by experience ss6 interesting, ss7 
SUDEP has additional ‘weight’ ss8 
 
Breaking Good News – ambivalence discussing sudep 
Discuss because of FAI – good thing ss5 – bad thing ss3 –pressure, bad thing ss7 
Uk more litigious and educated so will discuss SUDEP more at diagnosis ss8 
Consider important to discuss cf ss4 
Sceptical of the FAI ss10 
Clinical judgement mentioning risk factors 
Hopes of discussing SUDEP: 
SUDEP for adherence 
SUDEP to share info [patients have a right to know?  Help increase adherence from health 
model – actually need to increase understanding that medication is not harmful] 
SUDEP for engagement 
View SUDEP as a positive cf ss4 (because anticipating distress??) 
Impact of communicating - Unaware of effect of communicating SUDEP ss8 
Impact – conversations make a difference ss6 ss7 ss9 (cf health model) 
BBN 
Ambivalence 
Definitely not BBN ss3 ss5 
Same ss4 ss7 
Definitely – ss9 
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Falsely Anticipating distress 
Patients not upset by SUDEP info cf SS3 – concerned ss4 ss6 react well –this is surprising 
ss8, possibly because avoid discussing when distressed ss8   
Patient not surprised ss7 cf ss3 ss4 ss8 this is surprising itself ss9  cf ss10 - Sudep not 
surprising given dramatic nature of seizures 
Driving more important than SUDEP 
SUDEP helpful for chronic 
Relatives more worried than patients 
no experience of difficult SUDEP conversation cf ss3 ss10 
patients react well better if they have read about it ss5 cf ss7 
epilepsy diagnosis worse than SUDEP 
Rare for patients to ask more about SUDEP  ss6 ss8 
Chronic uncontrolled patients can become unduly worried about SUDEP ss8  
more fear in medics than patients Ss5  ss10 (colleagues activated patients would respond 
badly to SUDEP) 
anticipating anxiety - impact of discussing SUDEP after epilepsy diagnosis 
even in chronic patients – unwise to mention ss3 
emphasise rarity – minimise risk 
gentle delivery  
Clinicians reaction 
Not distressed discussing SUDEP cf ss4 ss6 – not initially ss6 – interesting, not bothered 
despite not thinking they should discuss SUDEP ss7 ss8 – possibly because have seen their 
natural reaction 
Uncomfortable answering questions at first 
More worry about getting epilepsy controlled than sudep (this is clinicians perceptions, 
they don’t actually know this) 
SUDEP not difficult in relation to other conditions – similar to asthma diabetes ss3 cf 
ss7ss8 
Support 
Encouraged to share difficult experiences (Reg) 
Discuss with colleagues – feedback 
Avoidance of acknowledging support/feelings? Ss6 logistics ss7 ss8 ss9 ss9-discuss with 
family ss10 interesting 
 
Pressure hinders effective communication 
Time pressure - Problem is discussing SUDEP at diagnosis ss2 ss6 ss8 
Pressure to get diagnosis correct 
Patients priority isn’t SUDEP - Patients should decide relevance of discussing SUDEP ss6 
is clinical practice best influenced by legal system? Ss3 ss4 
information overload 
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Appendix E: Accepted Research Protocol 
 
Cover Page 
 
Name of assessment: MRP Proposal 
 
Title: Clinician experiences of educating patients about SUDEP: How to talk about 
death when required to do so? 
 
Matriculation Number: 2109093 
 
Date of submission: 23/05/2015 
 
Version number: 8.4 
 
Word count: 3,293 
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Abstract 
 
Sudden Unexplained Death in Epilepsy (SUDEP) occurs in roughly 1/1000 patients 
with epilepsy.  Upon diagnosis, UK guidelines specify that patients should be given 
information about how to lower their risk of SUDEP.  Despite this, research 
demonstrates that clinicians often fail to have SUDEP conversations with their 
patients.  Although numerous factors affect clinicians' experiences of Breaking Bad 
News (BBN), the research into clinicians' experiences of discussing SUDEP is 
limited to an American study.  Given that the American SUDEP guidelines are not 
as prescriptive as the Scottish guidelines, their experience is different.  This 
research is interested in understanding the experiences of clinicians in Scotland 
when discussing SUDEP with their patients.  Neurologists will be interviewed about 
their experiences of discussing SUDEP with patients.  Line by line analysis of 
transcripts will help identify salient themes in the clinicians' experiences.  It is hoped 
this research will identify support for practice.  
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Introduction 
 
It has been argued that in the 20th century the risk of death due to epilepsy became 
minimised and then denied, despite the evidence this was not the case (Hanna & 
Panelli, 2011).  It was not until 1996 that the term ‘Sudden Unexplained Death in 
Epilepsy’ (SUDEP) was proposed.  SUDEP refers to the death of a patient with 
epilepsy which appears to occur without a specific reason (Nashef, 1997).  Death 
can occur with or without the presence of a seizure (but not due to status 
epilepticus), be witnessed or un-witnessed, and the term excludes deaths that have 
occurred due to toxicological or anatomical reasons (Scorza, Cysneiros, 
Albuquerque, Scattolini, & Arida, 2011).   Despite the name, people with epilepsy 
can take actions to reduce their risk of SUDEP.  Chiefly amongst these, people are 
encouraged to ensure their seizures are well controlled (i.e. occurring at a minimal 
rate) by adherence to anti-epileptic medication (Hughes, 2009; Scorza, Arida, Terra 
& Cavelheiro, 2010).  Other risk factors for SUDEP include: having a greater yearly 
frequency of generalised tonic-clonic seizures, an early age of onset (the highest 
SUDEP risk occurs in those diagnosed before the age of 16 (Hesdorffer et al., 
2011)), winter temperatures, and medication use (with polytherapy carrying a higher 
risk (Scorza et al., 2011)).  SUDEP is a rare event for people with epilepsy, with an 
incident rate of around 1/1000 (Gayateri, Morrall, & Jain, 2010).     
 
NICE guidelines specify that following a first seizure, patients should see a specialist 
in the management of the epilepsies (NICE, 2012).  Discussions regarding SUDEP 
with patients should contain ‘tailored information’ that ‘takes account of the small but 
definite risk of SUDEP’ (NICE, 2012, Section 1.3.13, p16) however, access to this 
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information should depend on the certainty of the diagnosis (NICE, 2012).  The 
American Epilepsy Society and the Institute of Medicine recommend that the 
increased risk of death associated with Epilepsy be disclosed to patients (Hirsch et 
al., 2011; Institute of Medicine, 2012).  
 
Harden, Tonberg, Chin, McLellan, and Duncan (2014) interviewed adults (aged 18-
29) and found they were keen to have a SUDEP discussion with their clinician.  Nair, 
Jack, Meaney, and Ronen (2013) conducted focus groups with parents of children 
with epilepsy and found that they also wished to be informed about SUDEP during 
their first discussion of epilepsy.  Additionally, Nair et al. (2013) noted that parents 
were ‘emphatic’ that they should not first learn about SUDEP from the internet or an 
information leaflet.  
 
Despite the wishes of patients and the guideline suggestions, clinicians are not 
regularly having SUDEP discussions with their patients.  Morton, Richardson and 
Duncan (2006) analysed 387 questionnaires when surveying the practice habits of 
UK based neurologists.  Around 70% discussed SUDEP with ‘very few’ or ‘none’ of 
their patients.  Similarly, of 1200 American and Canadian neurologists surveyed, 
less than 7% reported they were routinely discussing SUDEP with all patients 
(Friedman, Donner, Stephens, Wright & Devinsky, 2012).        
 
Friedman et al. (2012) reported that a perceived negative reaction to discussions of 
SUDEP were common in their US and Canadian sample of Neurologists.  This 
reaction is perhaps understandable given the findings of research on breaking bad 
news (BBN).  Clinicians may fear a negative response from patients during BBN 
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experiences, and clinicians can feel responsible for the bad news (Schildmann, 
Cushing, Doyal & Vollmann, 2005; Tesser, Rosen, & Tesser; 1971).  BBN is 
especially difficult when there are limited options for treatment (Ptacek & Eberhardt, 
1996), or if there is a feeling of inadequacy treating an uncontrollable disease (DoH, 
2003).   
 
Clinicians value a sense of autonomy regarding the disclosure of bad news.  In a 
survey of FY1/FY2 Doctor equivalents, Schildmann et al. (2005) found that although 
the majority of clinicians believed patients should be aware of life-threatening 
illnesses, a third felt that Doctors should be able to decide whether to give patients 
bad news or not.  Even experienced clinicians appear to find BBN experiences 
emotionally difficult (Ptacek, Ptacek & Ellison, 2001) and it is recognised that a lack 
of emotional support from healthcare colleagues can act as an ‘institutional barrier’ 
to good practice (Dosanjh, Barnes, & Bhandari, 2001). 
 
Miller, Young, Friedman, Buelow, and Devinsky (2014) used a qualitative approach 
to understand the practice of American clinicians (Epileptologists, Neurologists, and 
Advanced Practice Nurses) when discussing SUDEP.  A theme of ‘moral 
accountability’ was present when clinicians had some doubt whether to discuss 
SUDEP with their patients or not.  Clinicians wanted to wait until rapport was built 
with their patients before discussing SUDEP and there was a reluctance to discuss 
SUDEP if all treatment options had been tried.  
 
Scottish guidelines consider SUDEP to be essential information for patients (SIGN, 
2005).  Neurologists who work in Scotland are also likely to be aware of a judge-led 
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fatal accident enquiry into the deaths of Erin Casey and Christina Fiorre Ilia (2011).  
This established that two Scottish Health Boards were at fault for not informing these 
patients, and their parents, of the risk of SUDEP.  One recommendation was the 
‘vast majority’ of patients should be informed about SUDEP or it should be recorded 
as to why this did not take place.  Health Boards can therefore expect a SUDEP 
discussion to be held with the vast majority of patients following an initial diagnosis.  
Waddell, McColl, and Turner (2013), in a retrospective analysis of patients who 
attended a specialist epilepsy clinic in Scotland, found that a documented discussion 
of SUDEP occurred in only 4% of the 345 case notes examined.   
 
The proposed study is interested in understanding how the Scottish guidelines and 
legislative context has affected the experience of Neurologists when discussing 
SUDEP.  This study will also investigate the resources clinicians employ to enable 
this discussion.  This research will help identify potential methods of support to 
facilitate SUDEP discussions between neurologist and patient.  Additionally, this 
research may provide a useful comparative model for countries, health boards or 
organisations that are considering their guideline recommendations for how SUDEP 
is discussed with patients.       
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Aim 
 
To explore the experiences of Neurologists when discussing SUDEP with their 
patients and develop themes to account for these.   
 
The initial objectives of the proposed study will be to understand how the 
participants discuss SUDEP; how they classify good and bad experiences when 
discussing SUDEP; methods of support utilised or envisioned; feelings about the 
legal/legislative context to discuss SUDEP; as well as identifying if similar themes 
identified in previous research are present (Miller et al., 2014).   
    
Methods 
 
Participants 
 
Participants in the study will be practicing Consultant Neurologists with at least one 
year’s experience managing patients with seizures and epilepsy as a Consultant in 
Scotland.  Less experienced Registrar Doctors will also be approached for 
interviews. Registrar Doctors will be eligible for inclusion if they have worked for any 
length of time in a neurology placement and have had a minimum of two discussions 
about SUDEP. 
 
Recruitment Procedures 
 
The Field Supervisor (a Consultant Neurologist) will send details of the proposed 
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study to the West of Scotland Neurology email circulation list.  This list goes to 
approximately 30 Neurologists working across the West of Scotland through NHS 
Greater Glasgow and Clyde Health Board.  Registrar Doctors are also subscribed 
to this list.  This will request that the researcher attend a meeting of the group in 
September 2015 to present information about the research and recruit participants 
directly.  Participants will be given a participant information sheet, asked to consent 
to the research and arrange interview times, or provide contact details, at this stage.  
The researcher will ask that the Field Supervisor emails all members of the email 
circulation list following the lunchtime meeting.  The email will give information about 
the research and ask members to contact the researcher or Field Supervisor if 
interested in participating.  Registrar doctors will be informed that their choice to 
participate in research will not affect their training and any data would be 
confidential.     
 
Participants will be contacted to arrange interview times and the researcher will 
bring a participant information sheet and allow time to answer questions prior to the 
interview beginning so that informed consent can be obtained.  Participants will be 
asked if they wish to provide contact details so that the researcher can arrange a 
follow up appointment if required. 
 
Qualitative Design and Research Procedures 
 
A thematic analysis will explore the experiences of clinicians when discussing 
SUDEP with patients.  The analysis will take a contextualist approach focussing 
primarily on the manner neurologists make sense of their experiences, while 
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retaining the scope to analyse how broader contextual factors may have influenced 
their understanding.  The analysis will focus on providing a description of the data 
set as a whole, rather than looking at one aspect of the data in detail.  The 
researcher will use an inductive approach to analysis (Braun & Clarke, 2006) as a 
pre-existing coding frame will not be used and themes will be constructed from the 
data itself, rather than from pre-existing theory.  Themes will primarily be identified 
using a semantic approach; taking themes from the explicit statements of 
participants. 
    
One-to-one interviews between the researcher and the interviewee will be recorded 
using a digital voice recorder.  Interviews will last between 30-60 minutes.  A set of 
questions will help guide discussions.  These questions were developed by 
examining the previous literature described above and with consultation of the 
Consultant Neurologist Field Supervisor.  Supplemental questions may be asked 
based on the content of the interviews.  The interview will be trialed with the 
Neurologist Field supervisor before conducting interviews with the participants. 
 
The research procedure will be conducted in line with Braun and Clarke’s (2006) 
proposed six phases of thematic analysis.  After conducting each interview, the 
transcriptions will be read and checked with the audio recording for accuracy.  
Through this process the researcher will note down initial ideas and become familiar 
with the data.  It is proposed that the data is then coded line by line.  This will 
generate codes that account for ‘implicit concerns as well as explicit statements’ 
(Charmaz, 2006, p50).  Codes may also be generated for any interesting feature of 
the data (i.e. a code representing a group of other codes, or some broader aspect 
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of the data).  In effect the generated codes should in some way ‘evoke the data’ 
(Clarke and Braun, 2013).  
 
After initial coding, a process of focused coding will synthesise codes into salient 
themes that account for clinicians’ experiences.  Themes will be developed which 
represent a ‘patterned response or meaning within the data set’ (Braun & Clarke, 
2006, p82).  Ultimately, themes will explain something meaningful to the research 
question therefore the prevalence of the theme occurring in the data may or may 
not be important. 
 
Themes will be checked with the codes of transcripts, and with the data set as a 
whole to check for consistency or discrepancy.  As the process continues for each 
new interview transcription, the themes will become further refined.  Themes of 
interest can be verified and explored with other data sources so that the themes 
produced represent something meaningful to the data set.  Negative cases will also 
be of interest should the data provide them (Strauss & Corbin, 1990).  The final 
report will include a description of each theme found with examples from the data 
set.  
 
Data Saturation 
 
Analysis will continue until data saturation is achieved; this will be indicated when 
novel themes are no longer identified in the data set.  This may involve follow up 
interviews with some clinicians and the possibility of conducting interviews with 
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Registrar Doctors.  It is suggested that at least 6 participants are required at a 
minimum to evaluate when data saturation may occur. 
 
Reflexivity 
 
Blumer (1954) describes the assumptions and prior knowledge of a grounded theory 
researcher as ‘sensitizing concepts’.  Therefore, the researcher’s background as a 
Trainee Clinical Psychologist will be relevant.  Issues of support and the 
psychological impact of breaking bad news have already been mentioned in this 
proposal as these are potential areas of interest to the researcher.  The researcher’s 
own thoughts and interpretations will be monitored by keeping a reflective log 
throughout the research process.  Rather than considering the researcher’s opinions 
as hindering the research, it is acknowledged that these are fundamental to the 
process and in deriving a theory. 
 
Settings, Equipment and Materials 
 
The researcher will use a digital voice recorder, transcribing equipment and an 
encrypted laptop.  The researcher will travel out to interview clinicians in their NHS 
work setting.  The researcher will ask that there is a quiet room available for 45-60 
minutes that is suitable for the use of recording equipment.  If it is not possible to 
arrange a face to face interview the use of Skype™ will be considered.   
 
Financial Issues 
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Travel to potential sites will be claimed from the NHS employer.  It is anticipated that 
the only costs incurred will be for the photocopying of consent and information 
forms. 
 
Health and Safety Issues 
 
The researcher will follow the health and safety procedures of the NHS settings 
where the interviews take place.  The interviews will involve discussion of difficult 
experiences and the researcher will discuss support options available to the clinician 
if this is felt appropriate.  Identifying and exploring such experiences is an aim of the 
research, however, if the interviewee expresses ongoing psychological distress they 
will be signposted to relevant services. The clinicians will be informed that they can 
terminate the interview at any point. 
 
Ethical Issues 
 
Data will be anonymised and stored in line with the University of Glasgow’s policy 
on confidentiality data (http://www.gla.ac.uk/media/media_180727_en.pdf).  
Anonymity will be preserved by recruiting from across Scotland and redacting 
location and other identifying information from transcripts. An encrypted university 
laptop will be used to store the transcribed recording.  The transcription will be 
satisfactorily checked for accuracy against the recording, and then the recording will 
be erased.  Given that no NHS patients will be approached in this study, the 
researcher will obtain ethical approval for the research through the University of 
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Glasgow.  Approval for the study will be sought from the Research and Development 
team in Greater Glasgow and Clyde Health Board.   
 
Timetable 
 
A full proposal will be submitted for approval by March 16th 2015.  Ethical approval 
will be sought for the research by the beginning of July 2015.  Recruitment will begin 
in September 2015 and it is proposed that interviews are concluded by December 
2015.  The analysis will be written by February 2016 with a first draft completed by 
April 2016.     
 
Practical Applications 
 
This research will help develop testable hypothesis and may indicate why so few 
clinicians have SUDEP discussions with their patients (Morton et al., 2006; Waddell 
et al., 2013).  Given the legal imperative of these discussions, it is hoped this 
research will be useful in determining support to aid practice.  It is planned that the 
research be submitted for publication to a medical journal.      
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Appendix F: Ethical Approval from University of Glasgow MVLS. 
7 September 2015 
 
Dr Susan Turnbull 
Mental Health and Wellbeing 
Admin Building 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow G12 0XH 
 
 
Dear Dr Turnbull 
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Project Title: Clinician experiences of educating patients about Sudden 
Unexplained Death in Epilepsy (SUDEP): How to talk about death when required to 
do so? 
Project No: 20015005 
 
The College Ethics Committee has reviewed your application and has agreed that there is 
no objection on ethical grounds to the proposed study. It is happy therefore to approve the 
project, subject to the following conditions: 
 
 Project end date: 30 September 2016. 
 The data should be held securely for a period of ten years after the completion of the 
research project, or for longer if specified by the research funder or sponsor, in 
accordance with the University’s Code of Good Practice in Research: 
(http://www.gla.ac.uk/media/media_227599_en.pdf)   
 The research should be carried out only on the sites, and/or with the groups defined in 
the application. 
 Any proposed changes in the protocol should be submitted for reassessment, except 
when it is necessary to change the protocol to eliminate hazard to the subjects or where 
the change involves only the administrative aspects of the project. The Ethics 
Committee should be informed of any such changes. 
 You should submit a short end of study report to the Ethics Committee within 3 months 
of completion. 
 
Yours sincerely 
 
 
Professor William Martin 
College Ethics Officer  
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Appendix G:  The SUDEP Protocol diagram for initial diagnosis conversations 
 
 
 
 
 
 
 
 
 
 
Epilepsy diagnosis -
medication choices -
lifestyle impact - SUDEP
Won't discuss if patient 
distressed by diagnosis
SUDEP usually rasied 
by clinician
Use of standard 
'script'/phrase
May not use the word 
'death' - discuss in terms 
of risk/harm
Risks for SUDEP 
(lifestyle/nocturnal 
seizures)
Will usually document 
conversation to GP
Epilepsy Nurses can 
discuss in more detail
